Skip to main content

Julia A. Bridge, MD

Board Certifications

Anatomic Pathology, Clinical Cytogenetics

Fellowship

Molecular Biology, Cytogenetics

Interests

Molecular Diagnostics

Biography

ProPath, a Sonic Healthcare anatomic pathology practice, is privileged to include Julia A. Bridge, M.D., F.A.C.M.G., as a part of its dynamic medical staff and director of its cytotechnology and FISH department. Dr. Bridge is an award-winning, double board-certified pathologist who brings extensive professional medical experience to her position, including academic appointments and directorships. She also has a substantial list of publications and research activities.

Dr. Bridge earned her bachelor’s degree and medical degree at the University of Nebraska Medical Center in Omaha. She served a residency in pathology at the University of Kansas Medical Center in Kansas City. She completed a fellowship in cytogenetics at the University of Nebraska and University of Kansas Medical Centers. She then completed a fellowship in molecular biology at Southwest Biomedical Research Institute in Scottsdale, Arizona.

Dr. Bridge has a considerable professional background in a wide variety of healthcare and academic settings. She started as a clinical assistant professor in the Department of Pathology and Oncology at the University of Kansas Medical Center. She is a long-standing member of the University of Nebraska Medical Center medical team and has held many different positions while there. For over 20 years, she was the associate director of the UNMC Tissue Science Core Facility; director of the UNMC Tissue Procurement Bank Core Facility; and a professor in the Departments of Pathology, Microbiology, Pediatrics, Orthopedic Surgery, and the Division of Cytotechnology at UNMC, where she currently holds the appointment of clinical professor. Prior to joining ProPath, she was the division director of molecular pathology at The Translational Genomics Research Institute in Phoenix, AZ. She has held multiple consulting positions, most recently for Bayer and Ventana/Roche Global Advisory Board. She has been recognized as a top doctor by Omaha Magazine multiple times and was listed in the Best Doctors in America database for over a decade.

Dr. Bridge has published over 300 peer-reviewed articles in scientific and medical journals, over 60 books and book chapters, and has published and presented over 150 abstracts. She has been published in journals such as the Journal of Cutaneous Pathology, Cancer, Modern Pathology, American Journal of Surgical Pathology, and Diagnostic Cytopathology, among many others. She has published books and book chapters on the subjects of cancer pathology and cytogenetics. Dr. Bridge has been a peer reviewer for multiple scientific and medical journals, including The Journal of Molecular Diagnostics, Genes Chromosomes Cancer, The Lancet, Archives of Pathology & Laboratory Medicine, and the Journal of Pathology, among many others. She currently sits on the editorial boards of Cancer Genetics, American Journal of Translational Research, International Journal of Clinical and Experimental Pathology, and Modern Pathology.

Dr. Bridge is a member of a significant number of professional organizations, such as the American College of Medical Genetics, American Society of Clinical Oncology, American Society of Human Genetics, and the College of American Pathologists, among others.

Dr. Bridge holds full medical licensure and is board-certified in anatomic pathology and clinical cytogenetics.

Education

University of Nebraska Medical Center (BA)
Omaha, NE

University of Nebraska Medical Center (MD)
Omaha, NE

 

Postgraduate Training

Molecular Biology Fellowship
Southwest Biomedical Regional Institute
Scottsdale, AZ

Cytogenetics Fellowship
University of Nebraska
Omaha, NE

Cytogenetics Fellowship
University of Kansas Medical Center
Kansas City, KS

Pathology Residency
University of Kansas Medical Center
Kansas City, KS

  

Professional Memberships

American College of Medical Genetics

American Medical Association

American Society of Clinical Oncology

American Society of Human Genetics

Association for Molecular Pathology

College of American Pathologists

Connective Tissue Oncology Society

International Skeletal Society

International Society of Bone and Soft Tissue Pathology

Iowa Society of Cytology

Nebraska Pathology Society

Orthopaedic Research Society

The Great Plains Clinical Genetics Society

United States and Canadian Academy of Pathology

 

Peer-Reviewed Articles

  1. Surucu A, de Biase D, Ricci C, di Sciascio L, Collins K, Idrees MT, Ebare K, Fiorentino M, Bridge JA, Ulbright TM, Acosta AM. Beta-catenin alterations in post-chemotherapy yolk sac tumor, postpubertal-type with enteroblastic features. Mod Pathol. 2024 May 17:100513. doi: 10.1016/j.modpat.2024.100513. [Epub ahead of print]
      
  2. Mezzacappa FM, Smith FK, Zhang W, Gard A, Cabuk FK, Gonzalez-Gomez I, Monforte HL, Liang J, Singh O, Quezado MM, Aldape KD, Gokden M, Bridge JA, Chen J. Potential prognostic determinants for FET::CREB fusion-positive intracranial mesenchymal tumor. Acta Neuropathol Commun. 2024 Jan 30;12(1):17.

  3.  Machado I, Llombart-Bosch A, Charville GW, Navarro S, Dominguez Franjo MP, Bridge JA, Linos K. Sarcomas with EWSR1::non-ETS fusion (EWSR1::NFATC2 and EWSR1::PATZ1). Surg Pathol Clin. 2024 Mar;17(1):31-5. https://doi.org/10.1016/j.path.2023.07.001.

  4. Bridge JA, Halling KC, Moncur JT, Souers RJ, Hameed MR, Fernandes H, Roy A, Surrey L, Tafe LJ, Vasalos P, Lopez-Terrada DH. RNA sequencing for solid tumor fusion gene detection: proficiency testing practice and performance comparison. Arch Pathol Lab Med. 2023 Aug 3. doi: 10.5858/arpa.2023-0047-CP. [Epub ahead of print]

  5. Machado I, Agaimy A, Giner F, Navarro S, Michal M, Bridge JA, Claramunt R, López-Guerrero JA, Alcacer J, Linos K, Llombart-Bosch A. The value of GLI1 and p16 immunohistochemistry in the premolecular screening for GLI1-altered mesenchymal neoplasms. Virchows Arch. 2023 Nov 8. doi: 10.1007/s00428-023-03687-3. [Epub ahead of print].

  6. Crowley HM, Georgantzoglou N, Tse JY, Williams EA, Mata DA, Martin SS, Guitart J, Bridge JA, Linos K. Expanding our knowledge of molecular pathogenesis in histiocytoses: solitary soft tissue histiocytomas in children with a novel CLTC::SYK fusion. Am J Surg Pathol. 2023 Oct 1;47(10):1108-1115. Epub 2023 Aug 1.

  7. Gangahar CN, Dehner CA, Wang DP, Amini B, Hillen T, O’Conor C, Jennings SN, Byrnes K, Czerniak BA, Bridge JA, Schroeder MC, Jennings JW, Wang W-L, Chrisinger JSA. Intraosseous hibernoma: clinicopathologic, imaging and molecular analysis of 18 cases. Histopathology. 2023 Jul;83(1):40-48. Epub 2023 Apr 26.

  8. Acosta AM, Bridge JA, Dal Cin PS, Sholl LM, Cornejo KM, Fletcher CDM, Ulbright TM. Inflammatory and nested testicular sex cord tumor: a novel neoplasm with aggressive clinical behavior and frequent EWSR1::ATF1 gene fusions. Am J Surg Pathol. 2023 Apr 1;47(4):504-517. Epub 2023 Feb 15.

  9. Nicholas BA, Purohit R, Woods AD, Kannan K, Srinivasa G, Bridge JA, Kim J-H, Keller C. BCR-ABL is enriched in S- and G2-cell cycle phases. Leuk Res. 2023 Mar;126:107036. Epub 2023 Feb 8.

  10. Hagemann IS, Bridge JA, Tafe LJ, Hameed MR, Moncur JT, Bellizzi AM, Dolan M, Vasalos P, Kane ME, Souers RJ, Yemelyanova A. Current laboratory testing practices for assessment of ERBB2/HER2 in endometrial serous carcinoma and colorectal carcinoma. Arch Pathol Lab Med. 2023 Oct 1;147(10):1148-1157.

  11. Bovée JVMG, Webster F, Amary F, Baumhoer D, Bloem JLH, Bridge JA, Cates JMM, de Alava E, Dei Tos AP, Jones KB, Mahar A, Nielsen GP, Righi A, Wagner AJ, Yoshida A, Fletcher CDM. Datasets for the reporting of primary tumour in bone: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 2023 Mar;82(4):531-540. Epub 2022 Dec 20.

  12. Machado I, Hosler GA, Traves V, Claramunt R, Sanmartín O, Santonja C, Carvajal N, Zazo S, Requena L, Alfonso VS, Domenech EV, Llombart-Bosch A, Bridge JA, Linos K. Superficial GLI1-amplified mesenchymal neoplasms: expanding the spectrum of an emerging entity which reaches the realm of dermatopathology. J Cutan Pathol. 2023 Jun;50(6):487-499. Epub 2022 Nov 23.

  13. Zota V, Siegal GP, Kelly D, Bridge JA, Berglund A, Bui K, Khalil F, R Reed D, Altiok S, Magliocco A, Bui MM. Validation of PRKCB immunohistochemistry as a biomarker for the diagnosis of Ewing sarcoma. Fetal Pediatr Pathol. 2023 Apr;42(2):241-252. Epub 2022 Sep 5.

  14. Palsgrove DN, Rooper LM, Stevens TM, Shin C, Damm DD, Gagan J, Bridge JA, Thompson LDR, Koduru PR, Bishop JA. GLI1-altered soft tissue tumors of the head and neck: frequent oropharyngeal involvement, p16 immunoreactivity, and detectable alterations by DDIT3 break apart FISH. Head Neck Pathol. 2022 Dec;16(4):1146-1156. Epub 2022 Aug 6.

  15. Ramkissoon SH, Fernandes H, Lopez-Terrada DH, Hameed MR, Trembath DG, Bridge JA, Lindeman NI, Souers RJ, Vasalos P, Brat DJ, Moncur JT. Clinical laboratory testing practices in diffuse gliomas prior to publication of 2021 World Health Organization classification of central nervous system tumors. Arch Pathol Lab Med. 2022 May 1;147(5):518-524.

  16. Brat DJ, Aldape K, Bridge JA, Canoll P, Colman H, Hameed MR, Harris BT, Hattab EM, Huse JT, Jenkins RB, Lopez-Terrada DH, McDonald WC, Rodriguez FJ, Souter LH, Colasacco C, Thomas NE, Yount MH, van den Bent MJ, Perry A. Molecular biomarker testing for the diagnosis of diffuse gliomas. Arch Pathol Lab Med. 2022 May 1;146(5):547-574.

  17. Strait AM, Bridge JA, Iafrate AJ, Li MM, Xu F, Tsongalis GJ, Linos K. Mammary-type myofibroblastoma with leiomyomatous differentiation: a rare variant with potential pitfalls. Int J Surg Pathol. 2022 Apr;30(2):200-206.

  18. Patton A, Bridge JA, Liebner D, Chung C, Iwenofu OH. A YAP1::TFE3 cutaneous low-grade fibromyxoid neoplasm: a novel entity! Genes Chromosomes Cancer. 2022 Apr;61(4):194-199.

  19. Georgantzoglou N, Green D, Winnick KN, Sumegi J, Charville GW, Bridge JA, Linos K. Molecular investigation of ALK-rearranged epithelioid fibrous histiocytomas identifies CLTC as a novel fusion partner and evidence of fusion-independent transcription activation. Genes Chromosomes Cancer. 2022 Aug;61(8):471-480.

  20. Lindsey MS, Bridge JA, Douglas DS, Foster JT, Shalin SC, Gardner JM. Primary cutaneous alveolar rhabdomyosarcoma in an elderly adult: a rare potential mimic of merkel cell carcinoma. Am J Dermatopathol. 2022 Mar;44(3):218-222.

  21. Campbell K, Bridge JA, DiMaio D, Wilson J, Shalin SC, Gardner JM. Dermatofibrosarcoma protuberans with platelet-derived growth factor-D (PDGFD) rearrangement; two Cases with morphologically distinct presentations. J Cutan Pathol. 2022 Mar;49(3):274-277.

  22. Kerr DA, Thompson LDR, Tafe LJ, Jo VY, Neyaz A, Divakar P, Paydarfar JA, Pastel DA, Shirai K, John I, Seethala RR, Salgado CM, Deshpande V, Bridge JA, Kashofer K, Brcic I, Linos K. Clinicopathologic and genomic characterization of inflammatory myofibroblastic tumors of the head and neck: highlighting a novel fusion and potential diagnostic pitfall. Am J Surg Pathol. 2021 Dec 1;45(12):1707-1719.

  23. Cowan B, Klein E, Jansz K, Westenfelder K, Bradford T, Peterson C, Scherr D, Karsh L, Egerdie RB, Witjes JA, Trainer AT, Harris R, Goldfarb B, Flax S, Kroeger R, Boyd B, Liao J, Patel S, Bridge JA, Reuter V, Quigley N, Brown S, Zhao S, Satya M, Bates M, Simon IM, Campbell S, Lotan Y. Longitudinal follow-up and performance validation of a mRNA-based urine test (Xpert® Bladder Cancer Monitor) for surveillance in non-muscle invasive bladder cancer patients. BJU Int. 2021 Dec;128(6):713-721.

  24. Hughes CE, Correa H, Benedetti DJ, Smith B, Sumegi J, Bridge JA. Second report of PDE10A-BRAF fusion in pediatric spindle cell sarcoma with infantile fibrosarcoma-like morphology suggesting PDE10A-BRAF fusion is a recurrent event. Pediatr Dev Pathol. 2021 Nov-Dec;24(6):554-558.

  25. Al-Obaidy KI*Bridge JA*, Cheng L, Sumegi J, Reuter VE, Benayed R, Hameed M, Williamson SR, Hes O, Alruwaii FI, Segal JP, Wanjari P, Idrees MT, Nassiri M, Eble JN, Grignon DJ. EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma. Mod Pathol. 2021 Oct;34(10):1921-1934.  *Authors contributed equally

  26. Sadaf A, Szabo S, Ferguson K, Sorger JI, Sumegi J, Bridge JA, Pressey JG. Novel ARHGAP23-FER fusion in a metastatic spindle cell-predominant neoplasm with a myofibroblastic phenotype and a sustained metabolic response to lorlatinib. Cancer. 2021;127(22):4124-4130.

  27. Parra O, Bridge JA, Busam KJ, Shalin SC, Linos K. Dermal melanocytic tumor with CRTC1-TRIM11 fusion: report of two additional cases with review of the literature of an emerging entity. J Cutan Pathol. 2021 Jul;48(7):915-924.

  28. Wang H, Weiss VL, Hoffman RD, Abel T, Ho RH, Borinstein SC, Mannion K, Bridge JA, Black J, Liang JC. Salivary gland NUT carcinoma with prolonged survival in children: case illustration and systematic review of literature. Head Neck Pathol. 2021;15(1):236:243.

  29. Valenberg FJP van, Hiar AM, Wallace E, Bridge JA, Mayne DJ, Beqaj S, Sexton WJ, Lotan Y, Weizer AZ, Jansz GK, Stenzl A, Danella JF, Shepard B, Cline KJ, Williams MB, Montgomery S, David RD, Harris R, Klein EW, Bradford TJ, Wolk FN, Westenfelder KR, Trainer AF, Richardson TA, Egerdie RB, Goldfarb B, Zadra JA, Xixi L, Simon IM, Campbell SA, Bates MP, Higuchi RG, Witjes JA. Validation of an mRNA-based urine test for the detection of bladder cancer in patients with haematuria. Eur Urol Oncol. 2021;4(1):93-101.

  30. Linos K, Kerr DA, Sumegi J, Bridge JA. Pan-TRK immunoexpression in a superficial malignant ossifying fibromyxoid tumor with ZC3H7B-BCOR fusion: A potential obfuscating factor in the era of targeted therapy. J Cutan Pathol. 2021;48(2):340-342.

  31. Motanagh S, Bridge JA, Linos K. Acral fibromyxoma with loss of Rb1 by immunohistochemistry and fluorescence in situ hybridization: A diagnostically exploitable marker. J Cutan Pathol. 2021;48(2):295-301.

  32. Pettus JR, Kerr DA, Stan RV, Tse JY, Sverrisson EF, Bridge JA, Linos K. Primary myxoid and epithelioid mesenchymal tumor of the kidney with a novel GLI1-FOXO4 fusion. Genes Chromosomes Cancer. 2021;60(2):116-122.

  33. Bridge JA, Sumegi J, Royce T, Baker M, Linos K. A novel CLTC-FOSB gene fusion in pseudomyogenic hemangioendothelioma of bone. Genes Chromosomes Cancer. 2021;60(1):38-42.

  34. Parra O, Kerr DA, Bridge JA, Loehrer AP, Linos K. A case of YAP1 and NUTM1 rearranged porocarcinoma with corresponding immunohistochemical expression: Review of recent advances in poroma and porocarcinoma pathogenesis with potential diagnostic utility. J Cutan Pathol. 2021;48(1):95-101.

  35. Tran TAN, Bridge JA, Deharvengt SJ, Green DC, Linos K. Primary cutaneous adenomyoepithelioma ex spiradenoma with malignant histologic features, epithelial-myoepithelial carcinoma type: a first case report with molecular studies. Int J Surg Pathol. 2020;28(4):427-435.

  36. Mindiola-Romero AE, Maloney N, Bridge JA, Korkolopoulou P, Sakellariou S, Linos K. A concise review of angiofibroma of soft tissue: A rare newly described entity that can be encountered by dermatopathologists. J Cutan Pathol. 2020;47(2):179-185.

  37. Keegan A, Bridge JA, Lindeman NI, Long TA, Merker JD, Moncur JT, Montgomery ND, Nagarajan R, Rothberg PG, Routbort MJ, Vasalos P, Xian R, Kim AS. Proficiency testing of standardized samples shows high interlaboratory agreement for clinical next generation sequencing-based hematologic malignancy assays with survey material-specific differences in variant frequencies. Arch Pathol Lab Med. January 2020. doi:10.5858/arpa.2019-0352-CP

  38. Zhang L, Hwang S, Benayed R, Mullaney K, Rios K, Sukhadia P, Agaram N, Zhang Y, Bridge JA, Healey J, Athanasian E, Hameed M. Myositis ossificans-like soft tissue aneurysmal bone cyst: a clinical, radiological, and pathological study of seven cases with COL1A1-USP6 fusion and a novel ANGPTL2-USP6 fusion. Mod Pathol. 2020;33(8):1492-1504.

  39. Murphy LD, Orman GM, Bridge JA, Bajaj G, Gardner JM, Douglass DP. Primary superficial Ewing sarcoma: a unique entity? A case report including novel findings of ELF3 and TNFRSF14 copy number loss. J Cutan Pathol. 2020;47(10):970-975.

  40. Keung ES, Souers RJ, Bridge JA, Faquin WC, Graham RP, Hameed MR, Lewis JS Jr, Merker JD, Vasalos P, Moncur JT. Comparative performance of high-risk human papillomavirus RNA and DNA in situ hybridization on College of American Pathologists proficiency tests. Arch Pathol Lab Med. 2020;144(3):344-349.

  41. Dawson K, Bridge JA, Sumegi J, Royce T, Gardner JM, Shalin SC. Epithelioid fibrous histiocytoma with dot-like perinuclear ALK expression and PRKAR2A-ALK fusion. Am J Dermatopathol. 2020;42(11):861-864.

  42. Linos K, Kerr DA, Baker M, Wong S, Henderson E, Sumegi J, Bridge JA. Superficial malignant ossifying fibromyxoid tumors harboring the rare and recently described ZC3H7B-BCOR and PHF1-TFE3 fusions. J Cutan Pathol. 2020;47(10):934-945.

  43. Nguyen JK, Bridge JA, Joshi C, McKenney JK. Primary mammary analog secretory carcinoma (MASC) of the vulva with ETV6-NTRK3 fusion: a case report. Int J Gynecol Pathol. 2019;38(3):283-287.

  44. McMullen PD, Bridge JA, Blair EA, Yang CW, Collins J, Cipriani NA. Aneurysmal bone cyst of the maxillary sinus with USP6 rearrangement: case report of a rare entity and review of the literature. Head Neck Pathol. 2019;13(3):281-285.

  45. Castillo SA, Pham AK, Barton DT, Lefferts JA, Yan S, Bridge JA, Linos K. A diagnostically-challenging case of melanoma ex blue nevus with comprehensive molecular analysis, including the 23-gene expression signature (myPath melanoma). J Cutan Pathol. 2019;46(3):226-230.

  46. Maloley L, Helvey J, Bridge JA, DiMaio D, Ghate D, Kedar S. A tough NUT to crack: a 47-year-old with diplopia from a rare malignancy. J Neuroophthalmol. 2019;39(1):129-133.

  47. Tran TAN, Linos K, Carlson JA, Bridge JA. A primary cutaneous vascular neoplasm with histologic features of anastomosing hemangioma. J Cutan Pathol. 2019;46(5):353-357.

  48. Banach BS, Antic T, Bridge JA, Cipriani NA, Frye L, Krausz TN, Biernacka A. Fine-needle aspiration of dermatofibrosarcoma protuberans metastasizing to hemithorax with superior vena cava compression: Case report and literature review. Diagn Cytopathol. 2019;47(8):797-802.

  49. MacKinnon WF, Carter MD, Bridge JA, Tremaine RD, Walsh NMG. EWSR1-PBX3 gene fusion in cutaneous syncytial myoepithelioma. J Cutan Pathol. 2019;46(6):421-424.

  50. Stevens TM, Morlote D, Xiu J, Swensen J, Brandwein M, Miettinen MM, Gatalica Z, Bridge JA. NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum. Mod Pathol. 2019;32(6):764-773.

  51. Perkins AR, Macaulay RJB, Bui MM, Bridge JA, Etame AB. A frontal dural-based lesion in a 63-year old male. Brain Pathol. 2019;29(2):301-302.

  52. Rimm DL, Han G, Taube JM, Yi ES, Bridge JA. Reanalysis of the NCCN PD-L1 companion diagnostic assay study for lung cancer in the context of PD-L1 expression findings in triple-negative breast cancer. Breast Cancer Res. 2019;21(1):72.

  53. Valenberg FJPV, Hiar AM, Wallace E, Bridge JA, Mayne DJ, Beqaj S, Sexton WJ, Lotan Y, Weizer AZ, Jansz GK, Stenzl A, Danella JF, Shepard B, Cline KJ, Williams MB, Montgomery S, David RD, Harris R, Klein EW, Bradford TJ, Wolk FN, Westenfelder KR, Trainer AF, Richardson TA, Egerdie RB, Goldfarb B, Zadra JA, Ge S, Zhao S, Simon IM, Campbell SA, Rhees B, Bates MP, Higuchi RG, Witjes JA. Prospective validation of an mRNA-based urine test for surveillance of patients with bladder cancer. Eur Urol. 2019;75(5):853-860.

  54. Moncur JT, Bartley AN, Bridge JA, Kamel-Reid S, Lazar AJ, Lindeman NI, Long TA, Merker JD, Rai AJ, Rimm DL, Rothberg PG, Vasalos P, Kim AS. Performance comparison of different analytic methods in proficiency testing for mutations in the BRAF, EGFR, and KRAS genes: a study of the College of American Pathologists Molecular Oncology Committee. Arch Pathol Lab Med. 2019;143(10):1203-1211.

  55. Maloney N, Bridge JA, de Abreu F, Korkolopoulou P, Sakellariou S, Linos K. A novel MAP3K7CL-ERG fusion in a molecularly confirmed case of dermatofibrosarcoma protuberans with fibrosarcomatous transformation. J Cutan Pathol. 2019;46(7):532-537.

  56. Bridge JA, Sumegi J, Druta M, Bui MM, Henderson-Jackson E, Linos K, Baker M, Walko CM, Millis S, Brohl AS. Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma. Mod Pathol. 2019;32(11):1593-1604.

  57. Maloney N, LeBlanc RE, Sriharan A, Bridge JA, Linos K. Superficial nodular fasciitis with atypical presentations: report of 3 cases and review of recent molecular genetics. Am J Dermatopathol. 2019;41(12):931-936.

  58. Borinstein SC, Steppan D, Hayashi M, Loeb DM, Isakoff MS, Binitie O, Bridge JA, Brohl A, Stavas M, Shinohara ET, Meyer WH, Reed DR, Wagner LM. Consensus and controversies regarding the treatment of rhabdomyosarcoma. Pediatr Blood Cancer. 2018;65(2).

  59. Wallace E, Higuchi R, Satya M, McCann L, Sin ML, Bridge JA, Wei H, Zhang J, Wong E, Hiar A, Mach KE, Scherr D, Egerdie RB, Ohta S, Sexton WJ, Meng MV, Weizer AZ, Woods M, Jansz GK, Zadra J, Lotan Y, Liao JC. Development of a 90-minute integrated noninvasive urinary assay for bladder cancer detection. J Urol. 2018;199(3):655-662.

  60. Hollowoa B, Lamps LW, Mizell JS, English III GW, Bridge JA, Ram R, Gardner JM. Dedifferentiated liposarcoma mimicking a primary colon mass. Int J Surg Pathol. 2018;26(2):174-179.

  61. Kim AS, Bartley AN, Bridge JA, Kamel-Reid S, Lazar AJ, Lindeman NI, Long TA, Merker JD, Rai AJ, Rimm DL, Rothberg PG, Vasalos P, Moncur JT. Comparison of laboratory-developed tests and FDA-approved assays for BRAF, EGFR, and KRAS testing. JAMA Oncol. 2018;4(6):838-841.

  62. Maloney N, Giannikou K, Lefferts J, Bridge JA, Linos K. Expanding the histomorphologic spectrum of TFE3-rearranged perivascular epithelioid cell tumors. Hum Pathol. 2018;82:125-130.

  63. Laetsch TW, Roy A, Xu L, Black JO, Coffin C, Chin YY, Tian J,Spunt, S, Hawkins DS, Bridge JA, Parsons D, Skapek S. Undifferentiated sarcomas in children harbor clinically relevant oncogenic fusions and gene copy-number alterations: a report from the Children’s Oncology Group. Clin Cancer Res. 2018;24(16):3888-3897.

  64. Geiersbach KB, Bridge JA, Dolan M, Jennings LJ, Persons DL, Souers RJ, Tsuchiya KD, Vasalos PH, Moncur JT. Comparative performance of breast cancer human epidermal growth factor receptor 2 fluorescence in situ hybridization and brightfield in situ hybridization on College of American Pathologists proficiency tests. Arch Pathol Lab Med. 2018;142(10):1254-1259.

  65. Olson N, Rouhi O, Zhang L, Angeles CV, Bridge JA, Terrad DH, Royce T, Oclino D, Linos K. A novel case of an aggressive superficial spindle cell sarcoma in an adult resembling fibro sarcomatous dermatofibrosarcoma protuberans and harboring an EML4-NTRK3 fusion. J Cutan Pathol. 2018;45(12):933-939.

  66. Tao JJ, Wei G, Patel R, Fagan P, Hao X, Bridge JA, Arcila M, Al-Ahmadie H, Lee CH, Li G, Drilon A. ALK fusions in renal cell carcinoma: response to Entrectinib. JCO Precis Oncol. 2018;(2):1-8.

  67. Rimm DL, Han G, Taube JM, Yi ES, Bridge JA, Flieder DB, Homer R, West WW, Wu H, Roden AC, Fujimoto J, Yu H, Anders R, Kowalewski A, Rivard C, Rehman J, Batenchuk C, Burns V,  Hirsch FR, Wistuba II. A prospective, multi-institutional, pathologist-based assessment of 4 immunohistochemistry assays for PD-L1 expression in non-small cell lung cancer. JAMA Oncol. 2017;3(8):1051-1058.

  68. Dettloff J, Seethala RR, Stevens TM, Brandwein-Gensler M, Centeno BA,Otto K, Bridge JA, Bishop JA, Leon ME. Regarding Bocklage et al. “Regarding Dettloff et al. Mammary analog secretory carcinoma (MASC) involving the thyroid gland: a report of first 3 cases.” Head Neck Pathol. 2017;11(2):264-265. Head Neck Pathol. 2017;11(2):266-267.

  69. Dettloff J, Seethala RR, Stevens TM, , Brandwein-Gensler M, Centeno BA, Otto K, Bridge JABishop JA, Leon ME. Mammary analog secretory carcinoma (MASC) involving the thyroid gland: a report of the first 3 cases. Head Neck Pathol. 2017;11(2):124-130.

  70. Hery AL, Ornvold K, Memoli V, Bridge J, Linos K. A case of CIC-rearranged undifferentiated round-cell sarcoma with exclusive spindled morphology and diffuse CD99 positivity: a potential pitfall. Histopathology. 2017;70(2):314-316.

  71. Kuba MG, Wasserman A, Vnencak-Jones CL, Bridge JA, Gellert L, Hameed O, Giannico GA. Primary carcinoid tumor of the renal pelvis arising from intestinal metaplasia: an unusual histogenetic pathway? Appl Immunohistochem Mol Morphol  AIMM. 2017;25(7):e49-e57.

  72. Zajicek AK, Bridge JA, Akers JW, McGarry S V, Walker CW. Dedifferentiated liposarcoma of the lower extremity with low-grade dedifferentiation and low-grade osteosarcomatous component. Skeletal Radiol. 2017;46(2):265-271.

  73. Reed DR, Hayashi M, Wagner L, Binite O, Steppan DA, Brohl AS, Shinohara ER, Bridge JA, Loeb DM, Borinstein SC, Isakoff MS. Treatment pathway of bone sarcoma in children, adolescents, and young adults. Cancer. 2017;123(12):2206-2218.

  74. Bridge JA. Reverse transcription-polymerase chain reaction molecular testing of cytology specimens: Pre-analytic and analytic factors. Cancer Cytopathol. 2017;125(1):11-19.

  75. McGregor SM, Alikhan MB, John RA, Kotler H, Bridge JA, Mujacic I, Kadri S, Segal J, Krausz T. Melanotic PEComa of the sinonasal mucosa with NONO-TFE3 fusion: an elusive mimic of sinonasal melanoma. Am J Surg Pathol. 2017;41(5):717-722.

  76. Torabi A, Corral J, Gatalica Z, Swensen J, Moraveji S, Bridge JA. Primary renal sclerosing epithelioid fibrosarcoma: a case report and review of the literature. Pathology. 2017;49(4):447-450.

  77. Nagarajan R, Bartley AN, Bridge JA, Jennings LJ, Kamel-Reid S, Kim A, Lazar AJ, Moncur J, Rai AJ, Routbort MJ, Vasalos P, Merker JD. A window into clinical next-generation sequencing-based oncology testing practices. Arch Pathol Lab Med. 2017;141(12):1679-1685.

  78. Cajaiba MM, Jennings LJ, Rohan SM, Perez-Atayde A, Marino-Enriques A, Fletcher J, Geller J, Leuer K, Bridge JA. ALK-rearranged renal cell carcinomas in children. Genes Chromosomes Cancer. 2016;55(5):442-451.

  79. Liu J, Luo Z, Zhang L, Wang L, Nie Q, Wang ZF, Huang Z, Hu X, Gong L, Arrigo AP, Tang X, Xiang JW, Liu F, Deng M, Ji W, Hu W, Zhu JY, Chen B, Bridge JA, Hollingsworth MA, Gigantelli J, Liu Y, Nguyen QD, Li DW. The small heat shock protein αA-crystallin negatively regulates pancreatic tumorigenesis. Oncotarget. 2016 Oct 4;7(40):65808-65824. doi: 10.18632/oncotarget.11668.

  80. Lyle PL, Bridge JA, Simpson JF, Cates JM, Sanders ME. Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification. Histopathology. 2016;68(7):1040.

  81. Fang D, Gan H, Lee J-H, Han J, Wang Z, Riester SM, Jin L, Chen J, Zhou H, Wang J, Zhang H, Yang N, Bradley EW, Ho TH, Rubin BP, Bridge JA, Thibodeau SN, Ordog T, Chen Y, van Wijnen AJ, Oliveira AM, Xu RM, Westendorf JJ, Zhang Z. The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas. Science. 2016;352(6291):1344-1348.

  82. Simons SA, Bridge JA, Leon ME. Sinonasal small round blue cell tumors: An approach to diagnosis. Semin Diagn Pathol. 2016;33(2):91-103.

  83. Sholl LM, Andea A, Bridge JA, Liang C, Davis MA, Ehteshami M, Gangadhar TC, Kamel-Reid S, Lazar A, Raparia K, Siroy A, Watson K. Template for reporting results of biomarker testing of specimens from patients with melanoma. Arch Pathol Lab Med. 2016;140(4):355-357.

  84. Kapp JR, Diss T, Spicer J, Gandy M, Schrijver I, Jennings LJ, Li MM, Tsongalis GJ, Gonzalez de Castro D, Bridge JA, Wallace A, Deignan JL, Hing S, Butler R, Verghese E, Latham GJ, Hamoudi RA. Variation in pre-PCR processing of FFPE samples leads to discrepancies in BRAF and EGFR mutation detection: a diagnostic RING trial. J Clin Pathol. 2015;68(2):111-118.

  85. Lerman DM, Monument MJ, McIlvaine E, Liu X, Huang D, Monovich L, Beeler N, Gorlick RG, Marina NM, Womer RB, Bridge JA, Krailo MD, Randall RL, Lessnick SL. Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2015;62(5):759-765.

  86. Cykowski MD, Hicks J, Sandberg DI, Olar A, Bridge JA, Greipp PT, Navarro P, Kolodziej S, Bhattacharjee MB. Brain metastasis of crystal-deficient, CD68-positive alveolar soft part sarcoma: ultrastructural features and differential diagnosis. Ultrastruct Pathol. 2015;39(1):69-77.

  87. Smith SM, Coleman J, Bridge JA, Iwenofu OH. Molecular diagnostics in soft tissue sarcomas and gastrointestinal stromal tumors. J Surg Oncol. 2015;111(5):520-531.

  88. Ertoy Baydar D, Kosemehmetoglu K, Aydin O, Bridge JA, Buyukeren B, Aki FT. Primary sclerosing epithelioid fibrosarcoma of kidney with variant histomorphologic features: report of 2 cases and review of the literature. Diagn Pathol. 2015;10:186.

  89. Pages M, Lacroix L, Tauziede-Espariat A, Castel D, Daudigeos-Dubus E, Ridola V, Gilles S, Fina F, Andreiuolo F, Polivka M, Lechapt-Zalcman E, Puget S, Boddaert N, Liu X, Bridge J, Grill J, Chretien F, Varlet P. Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion. Acta Neuropathol Commun. 2015;3:85.

  90. Boyle TA, Bridge JA, Sabatini LM, Nowak JA, Vasalos P, Jennings LJ, Halling KC, College of American Pathologists Molecular Oncology Committee. Summary of microsatellite instability test results from laboratories participating in proficiency surveys: proficiency survey results from 2005 to 2012. Arch Pathol Lab Med. 2014;138(3):363-370.

  91. Smith NE, Deyrup AT, Mariño-Enriquez A, Fletcher JA, Bridge JA, Illei PB, Netto GJ, Argani P. VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy? Am J Surg Pathol. 2014;38(6):858-863.

  92. Kohsaka S, Shukla N, Ameur N, Ito T, Ng CKY, Wang L, Lim D, Marchetti A, Viale A, Pirun M, Socci N, Xin L, Scoit R, Bridge JA, Meyers P, Wexler L, Dogan S, Fletcher J, Reis-Filho JS, Ladanyi M. A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations. Nat Genet. 2014;46(6):595-600.

  93. Monument MJ, Johnson KM, McIlvaine E, Abegglen L, Watkins WS, Jorde LB, Womer RB, Beeler N, Monovich L, Lawlor ER, Bridge JA, Schiffman JD, Krailo MD, Randall RL, Lessnisk SL. Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children’s Oncology Group. PLoS One. 2014;9(8):e104378.

  94. Gosmann C, Mattarollo SR, Bridge JA, Frazer IH, Blumenthal A. IL-17 suppresses immune effector functions in human papillomavirus-associated epithelial hyperplasia. J Immunol. 2014;193(5):2248-2257.

  95. Linos K, Bridge JA, Edgar MA. MUC 4-negative FUS-CREB3L2 rearranged low-grade fibromyxoid sarcoma. Histopathology. 2014;65(5):722-724.

  96. Rudzinski ER, Anderson JR, Lyden ER, Bridge JA, Barr FG, Gastier-Foster JM, Bachmeyer K, Skapek SX, Wawkins DS, Teot LA, Parham DM. Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children’s oncology group. Am J Surg Pathol. 2014;38(5):654-659.

  97. Bridge JA. The role of cytogenetics and molecular diagnostics in the diagnosis of soft-tissue tumors. Mod Pathol. 2014;27 Suppl 1:S80-97.

  98. Smith RE, Kebriaei MA, Gard AP, McComb RD, Bridge JA, Lennarson PJ. Intracranial malignant triton tumor in a patient with neurofibromatosis type 1: case report and review of the literature. Brain Tumor Pathol. 2014;31(2):149-154.

  99. Pauli C, Fuchs B, Pfirrmann C, Bridge JA, Hofer S, Bode B. Response of an aggressive periosteal aneurysmal bone cyst (ABC) of the radius to denosumab therapy. World J Surg Oncol. 2014;12:17.

  100. Perry AM, Nelson M, Sanger WG, Bridge JA, Greiner TC. Cytogenetic abnormalities in follicular dendritic cell sarcoma: report of two cases and literature review. In Vivo. 2013;27(2):211-214.

  101. Bridge JA, Liu X-Q, Sumegi J, Nelson M, Reyes C, Bruch LA, Rosenblum M, Puccioni MJ, Bowdino BS, McComb RD. Identification of a novel, recurrent SLC44A1-PRKCA fusion in papillary glioneuronal tumor. Brain Pathol. 2013;23(2):121-128.

  102. Donnelly AD, Mukherjee MS, Lyden ER, Bridge JA, Lele SM, Wright N, McGaughey MF, Culberson AM, Horn AJ, Wedel WR, Radio SJ. Optimal z-axis scanning parameters for gynecologic cytology specimens. J Pathol Inform. 2013;4:38.

  103. Cate F, Bridge JA, Crispens MA, Keedy VL, Troutman A, Coffin CM, Fadare O. Composite uterine neoplasm with embryonal rhabdomyosarcoma and primitive neuroectodermal tumor components: rhabdomyosarcoma with divergent differentiation, variant of primitive neuroectodermal tumor, or unique entity? Hum Pathol. 2013;44(4):656-663.

  104. Bridge JA, Liu X-Q, Sumegi J, Nelson M, Reyes C, Bruch LA, Rosenblum M, Puccioni MJ, Bowdino BS, McComb RD. Identification of a novel, recurrent SLC44A1-PRKCA fusion in papillary glioneuronal tumor. Brain Pathol. 2013;23(2):121-128.

  105. Skapek SX, Anderson J, Barr FG, Bridge JA, Gastier-Foster J, Parham D, Rudzinski E, Triche T, Hawkins DS. PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children’s oncology group report. Pediatr Blood Cancer. 2013;60(9):1411-1417.

  106. Demicco EG, Wang W-L, Madewell JE, Huang D, Bui MM, Bridge JA, Meis JM. Osseous myxochondroid sarcoma: a detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the bone. Am J Surg Pathol. 2013;37(5):752-762.

  107. Rudzinski ER, Teot LA, Anderson JR, Moore J, Bridge JA, Barr FG, Gastier-Foster JM, Skapek SX, Hawkins DS, Parham DM. Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. Am J Clin Pathol. 2013;140(1):82-90.

  108. Nestheide S, Bridge JA, Barnes M, Frayer R, Sumegi J. Pharmacologic inhibition of epigenetic modification reveals targets of aberrant promoter methylation in Ewing sarcoma. Pediatr Blood Cancer. 2013;60(9):1437-1446.

  109. Viray H, Li K, Long TA, Vasalos P, Bridge JA, Jennings L, Halling K, Hameed M, Rimm DL. A prospective, multi-institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cells. Arch Pathol Lab Med. 2013;137(11):1545-1549.

  110. Edgar MA, Lauer SR, Bridge JA, Rizzo M. Soft tissue angiofibroma: report of 2 cases of a recently described tumor. Hum Pathol. 2013;44(3):438-441.

  111. Coleman MA, Bridge JA, Lane SW, Dixon CM, Hill GR, Wells JW, Thomas R, Steptoe RJ. Tolerance induction with gene-modified stem cells and immune-preserving conditioning in primed mice: restricting antigen to differentiated antigen-presenting cells permits efficacy. Blood. 2013;121(6):1049-1058.

  112. Bridge JA, Sanders K, Huang D, Nelson M, Neff JR, Muirhead D, Walker C, Seemayer TA, Sumegi J. Pericytoma with t(7;12) and ACTB-GLI1 fusion arising in bone. Hum Pathol. 2012;43(9):1524-1529.

  113. Shulman SC, Katzenstein H, Bridge JA, Bannister LL, Qayed M, Oskouei S, Shehata BM. Ewing sarcoma with 7;22 translocation: three new cases and clinicopathological characterization. Fetal Pediatr Pathol. 2012;31(6):341-348.

  114. Kesserwan C, Sokolic R, Cowen EW, Garabedian E, Heselmeyer-Haddad K, Lee CCR, Pittaluga S, Ortiz C, Baird K, Lopez-Terrada D, Bridge JA, Wayne AS, Candotti F. Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency. J Allergy Clin Immunol. 2012;129(3):762-769.e1.

  115. Dumont SN, Lazar AJ, Bridge JA, Benjamin RS, Trent JC. PAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by fluorescent in situ hybridization. J Cancer Res Clin Oncol. 2012;138(2):213-220.

  116. King L, López-Terrada D, Jakacky J, McCarville MB, Spunt SL, Bridge JA, Bahrami A. Primary intrathoracic dermatofibrosarcoma protuberans. Am J Surg Pathol. 2012;36(12):1897-1902.

  117. Bowen JM, Cates JM, Kash S, Itani D, Gonzalez A, Huang D, Oliveira A, Bridge JA. Genomic imbalances in benign metastasizing leiomyoma: characterization by conventional karyotypic, fluorescence in situ hybridization, and whole genome SNP array analysis. Cancer Genet. 2012;205(5):249-254.

  118. Bridge JA, Huang D, Sumegi J. Soft tissue tumors: Lipom: Chondroid lipoma. Atlas Genet Cytogenet Oncol Haematol. 2012;16(11):856-859.

  119. Behery R El, Bedrnicek J, Lazenby A, Nelson M, Grove J, Huang D, Smith R, Bridge JA. Translocation t(12;17)(q24.1;q21) as the sole anomaly in a nasal chondromesenchymal hamartoma arising in a patient with pleuropulmonary blastoma. Pediatr Dev Pathol. 2012;15(3):249-253.

  120. Pan Z, Sanger WG, Bridge JA, Hunter WJ, Siegal GP, Wei S. A novel t(6;13)(q15;q34) translocation in a giant cell reparative granuloma (solid aneurysmal bone cyst). Hum Pathol. 2012;43(6):952-957.

  121. Wang L, Motoi T, Khanin R, Olshen A, Mertens F, Bridge JA, Dal Cin P, Antonescu C, Singer S, Hameed M, Bovee J, Hogendoorn P, Socci N, Ladanyi M. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer. 2012;51(2):127-139.

  122. Steelman C, Katzenstein H, Parham D, Stockwell C, Ricketts R, Abramowsky C, Bridge JA, Sorensen PH, Kenney B, Olson T, Igbokwe A, Lopez-Terrada D, Shehata B. Unusual presentation of congenital infantile fibrosarcoma in seven infants with molecular-genetic analysis. Fetal Pediatr Pathol. 2011;30(5):329-337.

  123. Bridge JA, Cushman-Vokoun AM. Molecular diagnostics of soft tissue tumors. Arch Pathol Lab Med. 2011;135(5):588-601. doi:10.1043/2010-0594-RAIR.1

  124. Yu J, Deshmukh H, Payton JE, Dunham C, Scheithauer BW, Tihan T, Prayson RA, Guha A, Bridge JA, Ferner R, Lindberg GM, Gutmann RJ, Emnett RJ, Salavaggione L, Watson MA, Gutmann DH, Nagarajan R, Perry A. Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor. Clin Cancer Res. 2011;17(7):1924-1934.

  125. Shehata BM, Gupta NA, Katzenstein HM, Steelman CK, Wulkan ML, Gow KW, Bridge JA, Kenney BD, Thompson K, de Chadarévian JP, Abramowsky CR. Undifferentiated embryonal sarcoma of the liver is associated with mesenchymal hamartoma and multiple chromosomal abnormalities: a review of eleven cases. Pediatr Dev Pathol. 2011;14(2):111-116.

  126. Riddle ND, Gonzalez RJ, Bridge JA, Antonia S, Bui MM. A CD117 and CD34 immunoreactive sarcoma masquerading as a gastrointestinal stromal tumor: diagnostic pitfalls of ancillary studies in sarcoma. Cancer Control. 2011;18(3):152-159.

  127. Sumegi J, Nishio J, Nelson M, Frayer RW, Perry D, Bridge JA. A novel t(4;22)(q31;q12) produces an EWSR1-SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor. Mod Pathol. 2011;24(3):333-342.

  128. Debelenko L V, Raimondi SC, Daw N, Shivakumar BR, Huang D, Nelson M, Bridge JA. Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum. Mod Pathol. 2011;24(3):430-442.

  129. Bowe SN, Ozer E, Bridge JA, Brooks JSJ, Iwenofu OH. Primary intranodal epithelioid rhabdomyosarcoma. Am J Clin Pathol. 2011;136(4):587-592.

  130. Yasuda T, Suzuki K, Kanamori M, Hori T, Huang D, Bridge JA, Kimura T. Extraskeletal Ewing’s sarcoma of the thoracic epidural space: case report and review of the literature. Oncol Rep. 2011;26(3):711-715.

  131. Gatalica Z, Lilleberg SL, Monzon FA, Koul MS, Bridge JA, Knezetic, J, Legendre B, Sharma P, McCue P. Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes. Hum Pathol. 2011;42(12):1979-1988.

  132. Hou J, Dong J, Sun L, Geng L, Wang J, Zheng J, Li Y, Bridge JA, Hinrichs SH, Ding, SJ. Inhibition of phosphorylated c-Met in rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274. J Transl Med. 2011;9:64.

  133. Bridge JA, Bowen JM, Smith RB. The small round blue cell tumors of the sinonasal area. Head Neck Pathol. 2010;4(1):84-93.

  134. O’Donnell PH, Jensen A, Posadas EM, Bridge JA, Yeldandi A, Yang XJ, Stadler WM, Al-Ahmadie H. Renal medullary-like carcinoma in an adult without sickle cell hemoglobinopathy. Nat Rev Urol. 2010;7(2):110-114.

  135. Sumegi J, Streblow R, Frayer RW, Dal Cin P, Rosenberg A, Meloni-Ehrig A, Bridge JA. Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family. Genes Chromosomes Cancer. 2010;49(3):224-236.

  136. Nelson M, Perkins SL, Dave BJ, Coccia PF, Bridge JA, Lyden ER, Heerema NA, Lones MA, Harrison L, Cairo MS, Sanger WG. An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children’s Oncology Group study CCG-5961. Br J Haematol. 2010;148(4):600-610.

  137. Nezelof C, Seemayer TA, Bridge JA. Contributions of pediatrics and pediatric pathology to the body of knowledge regarding human disease. Hum Pathol. 2010;41(3):309-315.

  138. Romeo S, Duim RAJ, Bridge JA, Mertens F, De Jong D, Dal Cin P, Wijers-Koster PM, Debiec-Rychter M, Sciot R, Rosenberg A, Szuhai K, Hogendoorn PCW. Heterogeneous and complex rearrangements of chromosome arm 6q in chondromyxoid fibroma: delineation of breakpoints and analysis of candidate target genes. Am J Pathol. 2010;177(3):1365-1376.

  139. Huang D, Sumegi J, Dal Cin P, Reith JD, Yasuda T, Nelson M, Muirhead D, Bridge JA. C11orf95-MKL2 is the resulting fusion oncogene of t(11;16)(q13;p13) in chondroid lipoma. Genes Chromosomes Cancer. 2010;49(9):810-818.

  140. Kim HJ, Shen SS, Ayala AG, Ro JY, Truong L, Alvarez K, Bridge JA, Gatalica Z, Gonzalez-Berjon J, Monzon FA. Virtual-karyotyping with SNP microarrays in morphologically challenging renal cell neoplasms: a practical and useful diagnostic modality. Am J Surg Pathol. 2009;33(9):1276-1286.

  141. Monzon FA, Alvarez K, Gatalica Z, Bridge JA, Nelson M, Kim HJ, Hagenkord JM. Detection of chromosomal aberrations in renal tumors: a comparative study of conventional cytogenetics and virtual karyotyping with single-nucleotide polymorphism microarrays. Arch Pathol Lab Med. 2009;133(12):1917-1922.

  142. Alaggio R, Coffin CM, Weiss SW, Bridge JA, Issakov J, Oliveira AM, Folpe AL. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age. Am J Surg Pathol. 2009;33(5):645-658.

  143. Yasuda T, Perry KD, Nelson M, Bui MM, Nasir A, Goldschmidt, Gnepp DR, Bridge JA. Alveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literature. Hum Pathol. 2009;40(3):341-348.

  144. Giannico G, Holt GE, Homlar KC, Johnson J, Pinnt J, Bridge JA. Osteoblastoma characterized by a three-way translocation: report of a case and review of the literature. Cancer Genet Cytogenet. 2009;195(2):168-171.

  145. Yasuda T, Nishio J, Sumegi J, Kapels KM, Althof PA, Sawyer JR, Reith JD, Bridge JA. Aberrations of 6q13 mapped to the COL12A1 locus in chondromyxoid fibroma. Mod Pathol. 2009;22(11):1499-1506.

  146. Nugent SL, Dim DC, Bridge JA, Ioffe OB. Clear cell sarcoma of soft tissue metastatic to the ovaries: a heretofore unreported occurrence. Int J Gynecol Pathol. 2009;28(3):234-238.

  147. Qualman S, Lynch J, Bridge JA, Parham DP, Teot L, Meyer W, Pappo A. Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma : a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. Cancer. 2008;113(11):3242-3247.

  148. Camp MD, Tompkins RK, Spanier SS, Bridge JA, Bush CH. Best cases from the AFIP: Adamantinoma of the tibia and fibula with cytogenetic analysis. Radiographics. 2008;28(4):1215-1220.

  149. Torabi A, Lele SM, DiMaio D, Pinnt JC, Hess MM, Nelson M, Bridge JA. Lack of a common or characteristic cytogenetic anomaly in solitary fibrous tumor. Cancer Genet Cytogenet. 2008;181(1):60-64.

  150. Bridge JA. Contribution of cytogenetics to the management of poorly differentiated sarcomas. Ultrastruct Pathol. 2008;32(2):63-71.

  151. Rawlinson NJ, West WW, Nelson M, Bridge JA. Aggressive angiomyxoma with t(12;21) and HMGA2 rearrangement: report of a case and review of the literature. Cancer Genet Cytogenet. 2008;181(2):119-124.

  152. Scanlan D, Radio SJ, Nelson M, Zhou M, Streblow R, Prasad V, Reyes C, Perry D, Fletcher S, Bridge JA. Loss of the PTCH1 gene locus in cardiac fibroma. Cardiovasc Pathol. 2008;17(2):93-97.

  153. Bridge JA. Advantages and limitations of cytogenetic, molecular cytogenetic, and molecular diagnostic testing in mesenchymal neoplasms. J Orthop Sci. 2008;13(3):273-282.

  154. Streblow RC, Dafferner AJ, Nelson M, West W, Stevens RK, Gatalica Z, Novak D, Bridge JA. Imbalances of chromosomes 4, 9, and 12 are recurrent in the thecoma-fibroma group of ovarian stromal tumors. Cancer Genet Cytogenet. 2007;178(2):135-140.

  155. Kapels KM, Nishio J, Zhou M, Qualman SJ, Bridge JA. Embryonal rhabdomyosarcoma with a der(16)t(1;16) translocation. Cancer Genet Cytogenet. 2007;174(1):68-73.

  156. Stevens R, Almanaseer I, Gonzalez M, Caglar D, Knudson RA, Ketterling RP, Schrock D, Seemayer TA, Bridge JA. Analysis of HER2 gene amplification using an automated fluorescence in situ hybridization signal enumeration system. J Mol Diagn. 2007;9(2):144-150.

  157. Ellison DA, Parham DM, Bridge JA, Beckwith JB. Immunohistochemistry of primary malignant neuroepithelial tumors of the kidney: a potential source of confusion? A study of 30 cases from the National Wilms Tumor Study Pathology Center. Hum Pathol. 2007;38(2):205-211.

  158. Bridge JA. Genetic approaches to sarcoma diagnosis. Community Oncol. 2006;3(8):525-528.

  159. Sarosdy MF, Kahn PR, Ziffer MD, Love WR, Barkin J, Abara EO, Jansz K, Bridge JA, Johansson SL, Persons DL, Gibson JS. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria. J Urol. 2006;176(1):44-47.

  160. Nishio J, Gentry JD, Neff JR, Nelson M, Daniels W, Perry D, Gatalica Z, Bridge JA. Monoallelic deletion of the p53 gene through chromosomal translocation in a small cell osteosarcoma. Virchows Arch. 2006;448(6):852-856.

  161. Nishio J, Althof PA, Bailey JM, Zhou M, Neff JR, Barr FG, Parham DM, Qualman SJ, Bridge JA. Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma. Lab Invest. 2006;86(6):547-556.

  162. Barker KT, Spendlove HE, Banu NS, Bridge JA, Fisher C, Shipley J, Garrett M, Manyonda I, Houlston RS. No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas. Cancer Lett. 2006;235(1):136-140.

  163. Mazur MA, Gururangan S, Bridge JA, Cummings TJ, Mukundan S, Fuchs H, Larier N, Halperin EC. Intracranial Ewing sarcoma. Pediatr Blood Cancer. 2005;45(6):850-856.

  164. Standop J, Andrianifahanana M, Moniaux N, Schneider MB, Ulrich A, Brand RE, Wisecarver JL, Bridge JA, Buchler MW, Adrian TE, Batra SK, Pour PM. ErbB2 growth factor receptor, a marker for neuroendocrine cells? Pancreatology. 2005;5(1):44-58.

  165. Oliveira AM, Perez-Atayde AR, Dal Cin P, Gebhardt MC, Rosenberg AE, Bridge JA, Fletcher JA. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oncogene. 2005;24(21):3419-3426.

  166. Argani P, Laé M, Hutchinson B, Reuter VE, Collins MH, Perentesis J, Tomaszewski J, Brooks JSJ, Acs G, Bridge JA, Vargas SO, Davis IJ, Fisher DE, Ladanyi M. Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol. 2005;29(2):230-240.

  167. Caughron SK, Bridge JA, Bewtra CB, et al. Monosomy 22 as a diagnostic aid in a case of late recurrence of adult granulosa cell tumor of the ovary. Cancer Genet Cytogenet. 2005;156(1):83-85.

  168. Chiles MC, Parham DM, Qualman SJ, Teot LA, Bridge JA, Ullrich F, Barr FG, Meyer WA. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children’s Oncology Group. Pediatr Dev Pathol. 2005;8(1):141.

  169. Nishio J, Reith JD, Ogose A, Maale G, Neff JR, Bridge JA. Cytogenetic findings in clear cell chondrosarcoma. Cancer Genet Cytogenet. 2005;162(1):74-77.

  170. Olsen RJ, Lydiatt WM, Koepsell SA, Johansson S, Naumann S, Bridge JA, Neff JR, Hinrichs SH, Tarantolo S. C-erb-B2 (HER2/neu) expression in synovial sarcoma of the head and neck. Head Neck. 2005;27(10):883-892.

  171. Nishio J, Iwasaki H, Nabeshima K, Ishiguro M, Naumann S, Isayama T, Naito M, Kaneko Y, Kikuchi M, Bridge JA. Establishment of a new human epithelioid sarcoma cell line, FU-EPS-1: molecular cytogenetic characterization by use of spectral karyotyping and comparative genomic hybridization. Int J Oncol. 2005;27(2):361-369.

  172. Nishio J, Iwasaki H, Althof PA, Naumann S, Ishiguro M, Haraoka S, Iwashita A, Iwasaki A, Kaku Y, Kaneko Y, Kikuchi M, Bridge JA. Identification of a ring chromosome with spectral karyotyping in a pleural synovial sarcoma. Cancer Genet Cytogenet. 2005;160(2):174-178.
  173. Bridge RS, Bridge JA, Neff JR, Naumann S, Althof P, Bruch LA. Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic study. J Clin Pathol. 2004;57(11):1172-1178.

  174. Deyrup AT, Althof P, Zhou M, Solomon AR, Bridge JA, Weiss SW. Paraganglioma-like dermal melanocytic tumor: a unique entity distinct from cellular blue nevus, clear cell sarcoma, and cutaneous melanoma. Am J Surg Pathol. 2004;28(12):1579-1586.

  175. Cummings TJ, Bridge JA, Fukushima T. Extraskeletal myxoid chondrosarcoma of the jugular foramen. Clin Neuropathol. 2004;23(5):232-237.

  176. Bernal KL, Fahmy L, Remmenga S, Bridge JA, Baker J. Embryonal rhabdomyosarcoma (sarcoma botryoides) of the cervix presenting as a cervical polyp treated with fertility-sparing surgery and adjuvant chemotherapy. Gynecol Oncol. 2004;95(1):243-246.

  177. Parham DM, Bridge JA, Lukacs JL, Ding Y, Tryka AF, Sawyer JR. Cytogenetic distinction among benign fibro-osseous lesions of bone in children and adolescents: value of karyotypic findings in differential diagnosis. Pediatr Dev Pathol. 2004;7(2):148-158.

  178. Watson MA, Perry A, Tihan T, Prayson RA, Guha A, Bridge JA, Ferner R, Gutmann DH. Gene expression profiling reveals unique molecular subtypes of neurofibromatosis Type I-associated and sporadic malignant peripheral nerve sheath tumors. Brain Pathol. 2004;14(3):297-303.

  179. Bernal K, Nelson M, Neff JR, Nielsen SM, Bridge JA. Translocation (2;11)(q31;q12) is recurrent in collagenous fibroma (desmoplastic fibroblastoma). Cancer Genet Cytogenet. 2004;149(2):161-163.

  180. Oliveira AM, Hsi B-L, Weremowicz S, Perez-Atayde AR, Rosenberg AE, Dal Cin P, Joseph N, Bridge JA, Fletcher JA. USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst. Cancer Res. 2004;64(6):1920-1923.

  181. Althof PA, Ohmori K, Zhou M, Bailey J, Bridge RS, Nelson M, Neff JR, Bridge JA. Cytogenetic and molecular cytogenetic findings in 43 aneurysmal bone cysts: aberrations of 17p mapped to 17p13.2 by fluorescence in situ hybridization. Mod Pathol. 2004;17(5):518-525.

  182. Birch NC, Antonescu CR, Nelson M, Sarran L, Neff JR, Seemayer T, Bridge JA. Inconspicuous insertion 22;12 in myxoid/round cell liposarcoma accompanied by the secondary structural abnormality der(16)t(1;16). J Mol Diagn. 2003;5(3):191-194.

  183. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms. Cancer Genet Cytogenet. 2003;143(1):1-31.

  184. Nelson M, Perry D, Ginsburg G, Sanger WG, Neff JR, Bridge JA. Translocation (1;4)(p31;q34) in nonossifying fibroma. Cancer Genet Cytogenet. 2003;142(2):142-144.

  185. Ma Z, Hill DA, Collins MH, Morris SW, Sumegi J, Zhou M, Zuppan C, Bridge JA. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer. 2003;37(1):98-105.

  186. Buddingh EP, Naumann S, Nelson M, Neffa JR, Birch N, Bridge JA. Cytogenetic findings in benign cartilaginous neoplasms. Cancer Genet Cytogenet. 2003;141(2):164-168.

  187. Buddingh EP, Krallman P, Neff JR, Nelson M, Liu J, Bridge JA. Chromosome 6 abnormalities are recurrent in synovial chondromatosis. Cancer Genet Cytogenet. 2003;140(1):18-22.

  188. Laflamme C, Filion C, Bridge JA, Ladanyi M, Goldring MB, Labelle Y. The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas. Cancer Res. 2003;63(2):449-454.

  189. Bayani J, Zielenska M, Pandita A, Al-Romaih K, Karaskova J, Harrison K, Bridge JA, Sorensen P, Thorner P, Squire JA. Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas. Genes Chromosomes Cancer. 2003;36(1):7-16.

  190. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Dermatofibrosarcoma protuberans and giant cell fibroblastoma. Cancer Genet Cytogenet. 2003;140(1):1-12.

  191. Fritsch MK, Bridge JA, Schuster AE, Perlman EJ, Argani P. Performance characteristics of a reverse transcriptase-polymerase chain reaction assay for the detection of tumor-specific fusion transcripts from archival tissue. Pediatr Dev Pathol. 2003;6(1):43-53.

  192. Gorlick R, Anderson P, Andrulis I, Arndt C, Beardsley GP, Bernstein M, Bridge JA, Cheung N-K, Dome J, Ebb D, Gardner T, Gebhardt M, Grier H, Hansen M, Healey J, Helman L, Hock J, Houghton J, Houghton P, Huvos A, Khanna C, Kieran M, Kleinerman E, Ladanyi M, Lau C, Malkin D, Marina N, Meltzer P, Meyers P, Schofield D, Schwartz C, Smith M, Toretsky J, Tsokos M, Vanderputten D, Wexler L, Wigginton J, Withrow S, Anderson B. Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clin Cancer Res. 2003;9(15):5442-5453.

  193. Wang R, Titley JC, Lu Y-J, Summersgill BM, Bridge JA, Fisher C, Shipley J. Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma. Mod Pathol. 2003;16(8):778-785.

  194. Kuiper RP, Schepens M, Thijssen J, van Asseldonk M, van den Berg E, Bridge JA, Schuuring E, Schoenmakers EFPM, van Kessel AG. Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Hum Mol Genet. 2003;12(14):1661-1669.

  195. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. Cancer Genet Cytogenet. 2003;145(1):1-30.

  196. Folpe AL, McKenney JK, Bridge JA, Weiss SW. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol. 2002;26(9):1175-1183.

  197. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. desmoplastic small round-cell tumors. Cancer Genet Cytogenet. 2002;138(1):1-10.

  198. Sarosdy MF, Schellhammer P, Bokinsky G, Kahn P, Chao R, Yore L, Zadra J, Burzon D, Osher G, Bridge JA, Anderson S, Johansson SL, Lieber M, Soloway M, Flom K. Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J Urol. 2002;168(5):1950-1954.

  199. Barker KT, Bevan S, Wang R, Lu Y-J, Flanagan AM, Bridge JA, Fisher C, Finlayson CJ, Shipley J, Houlston RS. Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas. Br J Cancer. 2002;87(4):446-448.

  200. Feely MG, Boehm AK, Bridge RS, Lu Y-J, Flanagan A, Bridge JA, Fisher C, Finlayson CA, Shipley J, Houlston RS. Cytogenetic and molecular cytogenetic evidence of recurrent 8q24.1 loss in osteochondroma. Cancer Genet Cytogenet. 2002;137(2):102-107.

  201. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. gastrointestinal stromal tumors. Cancer Genet Cytogenet. 2002;135(1):1-22.

  202. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: alveolar soft part sarcoma. Cancer Genet Cytogenet. 2002;136(1):1-9.

  203. Barr FG, Qualman SJ, Macris MH, Melnyk N, Lawlor ER, Strzelecki DM, Triche TJ, Bridge JA, Sorensen PHB. Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions. Cancer Res. 2002;62(16):4704-4710.

  204. Sorensen PHB, Lynch JC, Qualman SJ, Lim JF, Tirabosco R, Maurer H, Crist W, Bridge JA, Triche TJ, Barr FG. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children’s oncology group. J Clin Oncol. 2002;20(11):2672-2679.

  205. Batanian JR, Bridge JA, Wickert R, Vogler C, Gadre B, Huang Y. EWS/FLI-1 fusion signal inserted into chromosome 11 in one patient with morphologic features of Ewing sarcoma, but lacking t(11;22). Cancer Genet Cytogenet. 2002;133(1):72-75.

  206. Naumann S, Krallman PA, Unni KK, Fidler ME, Neff JR, Bridge JA. Translocation der(13;21)(q10;q10) in skeletal and extraskeletal mesenchymal chondrosarcoma. Mod Pathol. 2002;15(5):572-576.

  207. Gisselsson D, Pålsson E, Höglund M, Domanski H, Mertens F, Pandis N, Sciot R, Dal Cin P, Bridge JA, Mandahl N. Differentially amplified chromosome 12 sequences in low- and high-grade osteosarcoma. Genes Chromosomes Cancer. 2002;33(2):133-140.

  208. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Synovial sarcoma. Cancer Genet Cytogenet. 2002;133(1):1-23.

  209. Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, Brennan MF, Bridge JA, Neff JR, Barr FG, Goldblum JR, Ali SZ, Shipley J, Cooper CS, Fisher C, Skytting B, Larsson O. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res. 2002;62(1):135-140.

  210. Bridge JA, Liu J, Qualman SJ, Suijkerbuijk R, Wenger G, Zhang J, Wan X, Baker SK, Sorensen P, Barr FG. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes Chromosomes Cancer. 2002;33(3):310-321.

  211. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: congenital (infantile) fibrosarcoma and mesoblastic nephroma. Cancer Genet Cytogenet. 2002;132(1):1-13.

  212. Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Goldblum JR, Ladanyi M. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res. 2001;7(12):3977-3987.

  213. Argani P, Antonescu CR, Illei PB, Lui MY, Timmons CF, Newbury R, Reuter VE, Garvin AJ, Perez-Atayde AR, Fletcher JA, Beckwith JB, Bridge JA, Ladanyi M. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159(1):179-192.

  214. Bridge JA, Kanamori M, Ma Z, et al. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol. 2001;159(2):411-415.

  215. Aubry MC, Bridge JA, Wickert R, Tazelaar HD. Primary monophasic synovial sarcoma of the pleura: five cases confirmed by the presence of SYT-SSX fusion transcript. Am J Surg Pathol. 2001;25(6):776-781.

  216. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: clear cell sarcoma (malignant melanoma of soft parts). Cancer Genet Cytogenet. 2001;130(1):1-7.

  217. Mendlick MR, Nelson M, Pickering D, Johansson SL, Seemayer TA, Neff JR, Vergara G, Rosenthal H, Bridge JA. Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma. Am J Surg Pathol. 2001;25(5):684-687.

  218. Wang R, Lu YJ, Fisher C, Bridge JA, Shipley J. Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-four-color karyotyping and comparative genomic hybridization analysis. Genes Chromosomes Cancer. 2001;31(1):54-64.

  219. Ladanyi M, Lui MY, Antonescu CR, Krause-Boehm A, Meindl A, Argani P, Healey JH, Ueda T, Yoshikawa H, Melon-Ehrig A, Sorensen PHB, Mertens F, Mandahl N, van den Berghe H, Sciot R, Dal Cin P, Bridge JA. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene. 2001;20(1):48-57.

  220. McComb EN, Feely MG, Neff JR, Johansson SL, Nelson M, Bridge JA. Cytogenetic instability, predominantly involving chromosome 1, is characteristic of elastofibroma. Cancer Genet Cytogenet. 2001;126(1):68-72.

  221. Ladanyi M, Woodruff JM, Scheithauer BW, Bridge JA, Barr FG, Goldblum JR, Fisher C, Perez-Atayde A, Dal Cin P, Fletcher CDM, Fletcher JA. Re: O’Sullivan MJ, Kyriakos M, Zhu X, Wick MR, Swanson PE, Dehner LP, Humphrey PA, Pfeifer JD: Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study. Mod Pathol. 2000;13:1336-46. Mod Pathol. 2001;14(7):733-737.

  222. Parham DM, Roloson GJ, Feely M, Green DM, Bridge JA, Beckwith JB. Primary malignant neuroepithelial tumors of the kidney: a clinicopathologic analysis of 146 adult and pediatric cases from the National Wilms’ Tumor Study Group Pathology Center. Am J Surg Pathol. 2001;25(2):133-146.

  223. Kanamori M, Antonescu CR, Scott M, Bridge RS, Neff JR, Spanier SS, Scarborough MT, Vergara G, Rosenthal HG, Bridge JA. Extra copies of chromosomes 7, 8, 12, 19, and 21 are recurrent in adamantinoma. J Mol Diagn. 2001;3(1):16-21.

  224. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Mesothelioma. Cancer Genet Cytogenet. 2001;127(2):93-110.

  225. Sandberg AA, Bridge JA. Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors. Cancer Genet Cytogenet. 2000;123(1):1-26.

  226. Bridge JA, Fidler ME, Neff JR, Degenhardt J, Wang M, Walker C, Dorfman HD, Baker SK, Seemayer TA. Adamantinoma-like Ewingʼs sarcoma: usefulness of genetic approaches in diagnosing small round cell tumors. Pathology Case Reviews. 2000;5(6):319-325.

  227. Feely MG, Fidler ME, Nelson M, Neff JR, Bridge JA. Cytogenetic findings in a case of epithelioid sarcoma and a review of the literature. Cancer Genet Cytogenet. 2000;119(2):155-157.

  228. Colleoni GW, Bridge JA, Garicochea B, Liu J, Filippa DA, Ladanyi M. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35). Am J Pathol. 2000;156(3):781-789.

  229. Bridge JA, Sandberg AA. Cytogenetic and molecular genetic techniques as adjunctive approaches in the diagnosis of bone and soft tissue tumors. Skeletal Radiol. 2000;29(5):249-258.

  230. Breiner JA, Meis-Kindblom J, Kindblom LG, Nelson M, Bridge JA. Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors). Cancer Genet Cytogenet. 2000;120(2):111-116.

  231. Boehm A, Squire J, Bayani J, Nelson M, Neff J, Bridge JA. Cytogenetic findings in 36 osteosarcoma specimens and a review of the literature. Pediatr Pathol Mol Med. 2000;19(5):359-376.

  232. Ganesan J, Spanier S, Bridge JA. Cytogenetic findings in a case of brown tumor associated with hyperparathyroidism. Cancer Genet Cytogenet. 2000;119(2):165-166.

  233. Safar A, Nelson M, Neff JR, Maale GE, Bayani J, Squire J, Bridge JA. Recurrent anomalies of 6q25 in chondromyxoid fibroma. Hum Pathol. 2000;31(3):306-311.

  234. Simons A, Schepens M, Jeuken J, Sprenger S, Van de Zande G, Bjerkehagen B, Forus A, Weibolt V, Molenaar I, van den Berg E, Myklebost O, Bridge JA, van Kessel AG, Suijkerbuijk R. Frequent loss of 9p21 (p16(INK4A)) and other genomic imbalances in human malignant fibrous histiocytoma. Cancer Genet Cytogenet. 2000;118(2):89-98.

  235. Ladanyi M, Bridge JA. Contribution of molecular genetic data to the classification of sarcomas. Hum Pathol. 2000;31(5):532-538.

  236. Van Gele M, Kaghad M, Leonard JH, Van Roy N, Naeyaert JM, Geerts ML, van Belle S, Cocquyt V, Bridge JA, Sciot R, De Wolf-Peeters C, De Paepe A, Caput D, Speleman F. Mutation analysis of P73 and TP53 in Merkel cell carcinoma. Br J Cancer. 2000;82(4):823-826.

  237. Bridge JA, Liu J, Weibolt V, Baker KS, Perry D, Kruger R, Qualman S, Barr F, Sorensen P, Triche T, Suijkerbuijk R. Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study. Genes Chromosomes Cancer. 2000;27(4):337-344.

  238. Bridge JA, Fidler ME, Neff JR, Degenhardt J, Wang M, Walker C, Dorfman HD, Baker KS, Seemayer TA. Adamantinoma-like Ewing’s sarcoma: genomic confirmation, phenotypic drift. Am J Surg Pathol. 1999;23(2):159-165.

  239. Bosilevac JM, Olsen RJ, Bridge JA, Hinrichs SH. Tumor cell viability in clear cell sarcoma requires DNA binding activity of the EWS/ATF1 fusion protein. J Biol Chem. 1999;274(49):34811-34818.

  240. Page TJ, Mata JE, Bridge JA, Siebler JC, Neff JR, Iversen PL. The cytotoxic effects of single-stranded telomere mimics on OMA-BL1 cells. Exp Cell Res. 1999;252(1):41-49.

  241. Rao VH, Singh RK, Delimont DC, Schaefer GB, Bridge JA, Neff JR, Sanger WG, Sappenfield JW, Buehler BA, Finnell RH. Interleukin-1beta upregulates MMP-9 expression in stromal cells of human giant cell tumor of bone. J Interferon Cytokine Res. 1999;19(10):1207-1217.

  242. Rao VH, Singh RK, Delimont DC, Finnell RH, Bridge JA, Neff JR, Garvin BP, Pickering DL, Sanger WG, Buehler BA, Schaefer GB. Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha. Int J Oncol. 1999;14(2):291-300.

  243. Breiner JA, Nelson M, Bredthauer BD, Neff JR, Bridge JA. Trisomy 8 and trisomy 14 in plantar fibromatosis. Cancer Genet Cytogenet. 1999;108(2):176-177.

  244. Buresh C, Seemayer T, Nelson M, Neff J, Dorfman HD, Bridge JA. t(X;4)(q22;q31.3) in giant cell reparative granuloma. Cancer Genet Cytogenet. 1999;115:80-81.

  245. Bridge JA, Swarts SJ, Buresh C, Nelson M, Degenhardt JM, Spanier S, Maale G, Neff JR. Trisomies 8 and 20 characterize a subgroup of benign fibrous lesions arising in both soft tissue and bone. Am J Pathol. 1999;154(3):729-733.

  246. Safar A, Wickert R, Nelson M, Neff JR, Bridge JA. Characterization of a variant SYT-SSX1 synovial sarcoma fusion transcript. Diagn Mol Pathol. 1998;7(5):283-287.

  247. Aue G, Hedges LK, Schwartz HS, Bridge JA, Neff JR, Butler MG. Clear cell sarcoma or malignant melanoma of soft parts: molecular analysis of microsatellite instability with clinical correlation. Cancer Genet Cytogenet. 1998;105(1):24-28.

  248. Petit MM, Swarts S, Bridge JA, Van de Ven WJ. Expression of reciprocal fusion transcripts of the HMGIC and LPP genes in parosteal lipoma. Cancer Genet Cytogenet. 1998;106(1):18-23.

  249. Bridge JA, Nelson M, Orndal C, Bhatia P, Neff JR. Clonal karyotypic abnormalities of the hereditary multiple exostoses chromosomal loci 8q24.1 (EXT1) and 11p11-12 (EXT2) in patients with sporadic and hereditary osteochondromas. Cancer. 1998;82(9):1657-1663.

  250. Lawlor ER, Mathers JA, Bainbridge T, Horsman DE, Kawai A, Healey JH, Huvos AG, Bridge JA, Ladanyi M, Sorensen PHB. Peripheral primitive neuroectodermal tumors in adults: documentation by molecular analysis. J Clin Oncol. 1998;16(3):1150-1157.

  251. Swarts SJ, Neff JR, Johansson SL, Nelson M, Bridge JA. Significance of abnormalities of chromosomes 5 and 8 in chondroblastoma. Clin Orthop Relat Res. 1998;(349):189-193.

  252. Bridge JA, Roberts CA, Degenhardt J, Walker C. Low-level chromosome 12 amplification in a primary lipoma of the lung: evidence for a pathogenic relationship with common adipose tissue tumors. Arch Pathol Lab Med. 1998;122(2):187-190.

  253. Weibolt VM, Buresh CJ, Roberts CA, Pickering D, Neff JR, Bridge JA. Involvement of 3q21 in nodular fasciitis. Cancer Genet Cytogenet. 1998;106(2):177-179.

  254. Day SJ, Nelson M, Rosenthal H, Vergara GG, Bridge JA. der(16)t(1;16)(q21;q13) as a secondary structural aberration in yet a third sarcoma, extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer. 1997;20(4):425-427.

  255. Rao VH, Singh RK, Bridge JA, Neff JR, Schaefer GB, Delimont DC, Dunn CM, Sanger WG, Buehler BA, Sawaya R, Nicolson GL, Rao JS. Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone. Clin Exp Metastasis. 1997;15(4):400-409.

  256. Cihak RA, Lydiatt WM, Lydiatt DD, Bridge JA. Synovial sarcoma of the head and neck: chromosomal translation (X;18) as a diagnostic aid. Head Neck. 1997;19(6):549-553.

  257. McComb EN, Neff JR, Johansson SL, Nelson M, Bridge JA. Chromosomal anomalies in a case of proliferative myositis. Cancer Genet Cytogenet. 1997;98(2):142-144.

  258. Swarts SJ, Neff JR, Nelson M, Johansson S, Bridge JA. Chromosomal abnormalities in low grade chondrosarcoma and a review of the literature. Cancer Genet Cytogenet. 1997;98(2):126-130.

  259. Krause AK, Hinrichs SH, Orndal C, DeBoer J, Neff JR, Bridge JA. Characterization of a human myxoid malignant fibrous histiocytoma cell line, OH931. Cancer Genet Cytogenet. 1997;94(2):138-143.

  260. Bridge JA, Nelson M, McComb E, McGuire MH, Rosenthal H, Vergara G, Maale GE, Spanier S, Neff JR. Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature. Cancer Genet Cytogenet. 1997;95(1):74-87.

  261. Brody RI, Ueda T, Hamelin A, Jhanwar SC, Bridge JA, Healey JH, Huvos AG, Gerald WL, Ladanyi M. Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma. Am J Pathol. 1997;150(3):1049-1058.

  262. Kenny-Moynihan MB, Hagen J, Richman B, McIntosh DG, Bridge JA. Loss of an X chromosome in aggressive angiomyxoma of female soft parts: a case report. Cancer Genet Cytogenet. 1996;89(1):61-64.

  263. Bridge JA, Meloni AM, Neff JR, et al. Deletion 5q in desmoid tumor and fluorescence in situ hybridization for chromosome 8 and/or 20 copy number. Cancer Genet Cytogenet. 1996;92(2):150-151.

  264. McComb EN, McComb RD, DeBoer JM, Neff JR, Bridge JA. Cytogenetic analysis of a malignant triton tumor and a malignant peripheral nerve sheath tumor and a review of the literature. Cancer Genet Cytogenet. 1996;91(1):8-12.

  265. Swarts S, Wisecarver J, Bridge JA. Significance of extra copies of chromosome 20 and the long arm of chromosome 2 in hepatoblastoma. Cancer Genet Cytogenet. 1996;91(1):65-67.

  266. McComb EN, Johansson SL, Neff JR, Nelson M, Bridge JA. Chromosomal anomalies exclusive of telomeric associations in giant cell tumor of bone. Cancer Genet Cytogenet. 1996;88(2):163-166.

  267. Bridge JA. Cytogenetics and experimental models. Current Opinion in Oncology. 1996;8(4):284-288.

  268. Swarts SJ, Neff JR, Johansson SL, Bridge JA. Cytogenetic analysis of dedifferentiated chondrosarcoma. Cancer Genet Cytogenet. 1996;89(1):49-51.

  269. Roberts CA, Seemayer TA, Neff JR, Alonso A, Nelson M, Bridge JA. Translocation (X;18) in primary synovial sarcoma of the lung. Cancer Genet Cytogenet. 1996;88(1):49-52.

  270. Wang Z, Taylor AK, Bridge JA. FMR1 fully expanded mutation with minimal methylation in a high functioning fragile X male. J Med Genet. 1996;33(5):376-378.

  271. Rao VH, Bridge JA, Neff JR, Schaefer GB, Viswanatha JK, Pollock RE, Rayford A, Stetler-Stevenson WG, Sawaya R, Rao JS. Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone. Clin Exp Metastasis. 1995;13(6):420-426.

  272. Bridge JA, DeBoer J, Walker CW, Neff JR. Translocation t(3;12)(q28;q14) in parosteal lipoma. Genes Chromosomes Cancer. 1995;12(1):70-72.

  273. Elmberger PG, Bridge JA, Noel SM, Neff JR, Walker CW, Johansson SL. Dedifferentiated chondrosarcoma: a report of a case with immunohistochemical, ultrastructural, and cytogenetic analysis and review of the literature. Int J Surg Pathol. 1995;2(4):319-328.

  274. Bridge JA. Cytogenetics and experimental models of sarcomas. Current Opinion in Oncology. 1995;7(4):333-339.

  275. Bridge JA, Pickering D, Neff JR. Cytogenetic and molecular cytogenetic analysis of sacral chordoma. Cancer Genet Cytogenet. 1994;75(1):23-25.

  276. Sinovic J, Bridge JA. Translocation (2;17) in recurrent dermatofibrosarcoma protuberans. Cancer Genet Cytogenet. 1994;75(2):156-157.

  277. Bridge JA, Dembinski A, DeBoer J, Travis J, Neff JR. Clonal chromosomal abnormalities in osteofibrous dysplasia. Implications for histopathogenesis and its relationship with adamantinoma. Cancer. 1994;73(6):1746-1752.

  278. Bridge JA, DeBoer J, Travis J, Johansson SL, Elmberger G, Noel SM, Neff JR. Simultaneous interphase cytogenetic analysis and fluorescence immunophenotyping of dedifferentiated chondrosarcoma. Implications for histopathogenesis. Am J Pathol. 1994;144(2):215-220.

  279. Travis JA, Sandberg AA, Neff JR, Bridge JA. Cytogenetic findings in malignant triton tumor. Genes Chromosomes Cancer. 1994;9(1):1-7.

  280. Bridge JA, Bhatia PS, Anderson JR, Neff JR. Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions. Cancer Genet Cytogenet. 1993;69(2):79-90.

  281. Tayyeb MT, Neff JR, Bridge JA. A case report of fibrolipoma with t(12;16)(q13;q24) [lead article]. Cancer Genet Cytogenet. 1993;67(2):145-146.

  282. Bridge JA. Cytogenetic and molecular cytogenetic techniques in orthopaedic surgery. J Bone Joint Surg Am. 1993;75(4):606-614.

  283. Meloni AM, Bridge JA, Sandberg AA. Reviews on chromosome studies in urological tumors. I. Renal tumors. J Urol. 1992;148(2 Pt 1):253-265.

  284. Travis JA, Bridge JA. Significance of both numerical and structural chromosomal abnormalities in clear cell sarcoma. Cancer Genet Cytogenet. 1992;64(2):104-106.

  285. Stephenson CF, Bridge JA, Sandberg AA. Cytogenetic and pathologic aspects of Ewing’s sarcoma and neuroectodermal tumors. Hum Pathol. 1992;23(11):1270-1277.

  286. DeBoer JM, Neff JR, Bridge JA. Cytogenetics of sacral chordoma. Cancer Genet Cytogenet. 1992;64(1):95-96.

  287. Bridge JA, Persons DL, Neff JR, Bhatia P. Clonal karyotypic aberrations in enchondromas. Cancer Detect Prev. 1992;16(4):215-219.

  288. Sinovic JF, Bridge JA, Neff JR. Ring chromosome in parosteal osteosarcoma. Clinical and diagnostic significance. Cancer Genet Cytogenet. 1992;62(1):50-52.

  289. Dembinski A, Bridge JA, Neff JR, Berger C, Sandberg AA. Trisomy 2 in proliferative fasciitis. Cancer Genet Cytogenet. 1992;60(1):27-30.

  290. Bridge JA, Sreekantaiah C, Mouron B, Neff JR, Sandberg AA, Wolman SR. Clonal chromosomal abnormalities in desmoid tumors. Implications for histopathogenesis. Cancer. 1992;69(2):430-436.

  291. Sandberg AA, Bridge JA. Techniques in cancer cytogenetics: an overview and update. Cancer Invest. 1992;10(2):163-172.

  292. Bridge JA, Neff JR, Mouron BJ. Giant cell tumor of bone. Chromosomal analysis of 48 specimens and review of the literature. Cancer Genet Cytogenet. 1992;58(1):2-13.

  293. Bridge JA, Sreekantaiah C, Neff JR, Sandberg AA. Cytogenetic findings in clear cell sarcoma of tendons and aponeuroses. Malignant melanoma of soft parts. Cancer Genet Cytogenet. 1991;52(1):101-106.

  294. Meloni A, Morgan R, Bridge JA, Erling MA, Lewin RJ, Sandberg AA. Cytogenetic findings in typical and atypical meningioma. Cancer Genet Cytogenet. 1991;51(1):35-39.

  295. Bridge JA, Leong SP, Burgess AC, Thompson F, Trent JM. Examination of clonal variants from human malignant melanoma studied by chromosome banding analysis. Melanoma Res. 1991;1(4):289-296.

  296. Persons DL, Bridge JA, Neff JR. Cytogenetic analysis of two sacral chordomas. Cancer Genet Cytogenet. 1991;56(2):197-201.

  297. Bridge JA, Mouron BJ, Neff JR, Bhatia PS. Significance of chromosomal abnormalities in a malignant giant cell tumor of bone. Cancer Genet Cytogenet. 1991;57(1):87-92.

  298. Sreekantaiah C, Bridge JA, Rao UN, Neff JR, Sandberg AA. Clonal chromosomal abnormalities in hemangiopericytoma. Cancer Genet Cytogenet. 1991;54(2):173-181.

  299. Bridge JA, Neff JR. Malignant cartilage tumors. Current Opinion in Orthopaedics. 1991:796-800.

  300. Pfeifer FM, Bridge JA, Neff JR, Mouron BJ. Cytogenetic findings in aneurysmal bone cysts. Genes Chromosomes Cancer. 1991;3(6):416-419.

  301. Bridge JA, Neff JR, Borek DA, Hackbarth DA. Primary skeletal Ewing’s sarcoma in Down syndrome. Cancer Genet Cytogenet. 1990;47(1):61-68.

  302. Bridge JA, Neff JR, Bhatia PS, Sanger WG, Murphey MD. Cytogenetic findings and biologic behavior of giant cell tumors of bone. Cancer. 1990;65(12):2697-2703.

  303. Bridge JA, Neff JR, Sandberg AA. Cytogenetic analysis of dermatofibrosarcoma protuberans. Cancer Genet Cytogenet. 1990;49(2):199-202.

  304. Bridge JA, Sanger WG, Neff JR, Hess MM. Cytogenetic findings in a primary malignant fibrous histiocytoma of bone and the lung metastasis. Pathology. 1990;22(1):16-19.

  305. Bridge JA, Neff JR, Bhatia PS, Sanger WG. Cytogenetic analysis of giant cell tumors of bone; diagnostic and prognostic implications. Chir Organi Mov. 1990;75(1 Suppl):187-188.

  306. Kepes JJ, Bridge JA, Flasschoen J. Penetration of neuronal perikarya by capillaries in chronic limbic encephalitis. J Neuropathol Exp Neurol. 1990;49(1):64-70.

  307. Bridge JA, Borek DA, Neff JR, Huntrakoon M. Chromosomal abnormalities in clear cell sarcoma. Implications for histogenesis. Am J Clin Pathol. 1990;93(1):26-31.

  308. Bridge JA, Rosenthal H, Sanger WG, Neff JR. Desmoplastic fibroma arising in fibrous dysplasia. Chromosomal analysis and review of the literature. Clin Orthop Relat Res. 1989;(247):272-278.

  309. Bridge JA, Sanger WG, Neff JR. Translocations involving chromosomes 2 and 13 in benign and malignant cartilaginous neoplasms. Cancer Genet Cytogenet. 1989;38(1):83-88.

  310. Bridge JA, McManus BM, Remmenga J, Cuppage FP. Complete heart block in the 18p-syndrome. Congenital calcification of the atrioventricular node. Arch Pathol Lab Med. 1989;113(5):539-541.

  311. Bridge JA, Patil S, Peterson J, Speaks S, Fatemi C, Williamson R, Sanger W. Two double translocation families. Kans Med. 1988;89(2):46-48.

  312. Bridge JA, Shaffer B, Neff JR, Sanger WG, Moran J. A complex translocation involving chromosomes 12 and 16 in a metastatic myxoid liposarcoma. Cancer Genet Cytogenet. 1988;34(1):119-120.

  313. Bridge JA, Bridge RS, Borek DA, Shaffer B, Norris CW. Translocation t(X;18) in orofacial synovial sarcoma. Cancer. 1988;62(5):935-937.

  314. Bridge JA, Sanger WG, Shaffer B, Neff JR. Cytogenetic findings in malignant fibrous histiocytoma. Cancer Genet Cytogenet. 1987;29(1):97-102.

  315. Sanger WG, Armitage JO, Bridge JA, Weisenburger DD, Fordyce R, Purtilo DT. Initial and subsequent cytogenetic studies in malignant lymphoma. Cancer. 1987;60(12):3014-3019.

  316. Bridge JA, Sanger W, Mosher G, Buehler B, Nelson, R, Welsh M, Newland J, Kafka M. Partial deletion of distal 17q. Am J Med Genet. 1985;21(2):225-229.

  317. Bridge JA, Sanger W, Mosher G, Olney A, Buehler B. Partial duplication of distal 17q. Am J Med Genet. 1985;22(2):229-235.

Book Chapters

WHO Classification of Tumours of Soft Tissue and Bone. 5th Edition

 

  1. Bridge JA, Hogendoorn PCW. Chondromyxoid fibroma. In: WHO Classification of Tumours Editorial Board, ed. WHO Classification of Paediatric Tumours. 5th ed. Lyon, France: IARC Press; 2023:613-615.
  2. Bridge JA, Hornick JL. Rhabdomyosarcoma of the thorax. In: WHO Classification of Tumours Editorial Board, ed. WHO Classification of Thoracic Tumours. 5th ed. Lyon, France: IARC Press; 2021:301-302.

  3. Akihiko Y, Bridge JA. Undifferentiated small round cell sarcomas. In: WHO Classification of Tumours Editorial Board, ed. WHO Classification of Thoracic Tumours. 5th ed. Lyon, France: IARC Press; 2021:316-318.

  4. Creytens D, Bridge JA. Deep (aggressive) angiomyxoma. In: WHO Classification of Tumours Editorial Board, ed. WHO Classification of Female Genital Tumours. 5th ed. Lyon, France: IARC Press; 2020:520-521.

  5. Antonescu CR, Bridge JA, Cunha IW, Dei Tos AP, Fletcher CDM, Folpe AL, Goldblum JR, Hornick JL, Miettinen M, Oda Y, eds. Chapter 1: Soft tissue tumours. In: WHO Classification of Tumours Editorial Board, ed. WHO Classification of Tumours of Soft Tissue and Bone. 5th Lyon, France: IARC Press; 2020:1-320.

  6. Black JO, Bridge JA, Pedeutour F. Lipoblastoma and lipoblastomatosis. In: WHO Classification of Tumours Editorial Board, ed. WHO Classification of Tumours of Soft Tissue and Bone. 5th Lyon, France: IARC Press; 2020:20-22.

  7. Bridge JA, Flucke U. Chondroid lipoma. In: WHO Classification of Tumours Editorial Board, ed. WHO Classification of Tumours of Soft Tissue and Bone. 5th Lyon, France: IARC Press; 2020:27-28.

  8. Miettinen M, Bridge JA. Desmoplastic fibroblastoma. In: WHO Classification of Tumours Editorial Board, ed. WHO Classification of Tumours of Soft Tissue and Bone. 5th Lyon, France: IARC Press; 2020:69-70.

  9. Nucci MR, Bridge JA. Deep (aggressive) angiomyxoma. In: WHO Classification of Tumours Editorial Board, ed. WHO Classification of Tumours of Soft Tissue and Bone. 5th Lyon, France: IARC Press; 2020:266-267.

  10. Billings SD, Panagopoulos I. Leiomyoma. In: WHO Classification of Tumours Editorial Board, ed. Bridge JA, section ed. & final reviewer. WHO Classification of Tumours of Soft Tissue and Bone. 5th Lyon, France: IARC Press; 2020:188-189.

  11. Watanabe R, Schafernak KT, Soares FA. EBV-associated smooth muscle tumour. In: WHO Classification of Tumours Editorial Board, ed. Bridge JA, section ed. & final reviewer. WHO Classification of Tumours of Soft Tissue and Bone. 5th Lyon, France: IARC Press; 2020:190-192.

  12. Fletcher CDM, Mertens F. Inflammatory leiomyosarcoma. In: WHO Classification of Tumours Editorial Board, ed. Bridge JA, section ed. & final reviewer. WHO Classification of Tumours of Soft Tissue and Bone. 5th Lyon, France: IARC Press; 2020:193-194.

  13. Dry SM, Frohling S. Leiomyosarcoma. In: WHO Classification of Tumours Editorial Board, ed. Bridge JA, section ed. & final reviewer. WHO Classification of Tumours of Soft Tissue and Bone. 5th Lyon, France: IARC Press; 2020:195-197.

  14. Bridge JA, ed. Chapter 2: Undifferentiated small round cell sarcomas of bone and soft tissue. In: WHO Classification of Tumours Editorial Board, ed. WHO Classification of Tumours of Soft Tissue and Bone. 5th Lyon, France: IARC Press; 2020:321-336.

  15. de Alava E, Lessnick SL, Stamenkovic I. Ewing sarcoma. In: WHO Classification of Tumours Editorial Board, ed. Bridge JA, section ed. & final reviewer. WHO Classification of Tumours of Soft Tissue and Bone. 5th Lyon, France: IARC Press; 2020:323-325.

  16. Le Loarer F, Szuhai K, Tirode F. Round cell sarcoma with EWSR1-non-ETS fusions. In: WHO Classification of Tumours Editorial Board, ed. Bridge JA, section ed. & final reviewer. WHO Classification of Tumours of Soft Tissue and Bone. 5th Lyon, France: IARC Press; 2020:326-329.

  17. Antonescu CR, Yoshida A. CIC-rearranged sarcoma. In: WHO Classification of Tumours Editorial Board, ed. Bridge JA, section ed. & final reviewer. WHO Classification of Tumours of Soft Tissue and Bone. 5th Lyon, France: IARC Press; 2020:330-332.

  18. Antonescu CR, Puls F, Tirode F. Sarcoma with BCOR genetic alterations. In: WHO Classification of Tumours Editorial Board, ed. Bridge JA, section ed. & final reviewer. WHO Classification of Tumours of Soft Tissue and Bone. 5th Lyon, France: IARC Press; 2020: 333-335.

  19. Bridge JA, Cleven AHG, Tirabosco R. Periosteal chondroma. In: WHO Classification of Tumours Editorial Board, ed. WHO Classification of Tumours of Soft Tissue and Bone. 5th Lyon, France: IARC Press; 2020:351-352.

  20. Hogendoorn PCW, Bloem JL, Bridge JA. Chondromyxoid fibroma. In: WHO Classification of Tumours Editorial Board, ed. WHO Classification of Tumours of Soft Tissue and Bone. 5th Lyon, France: IARC Press; 2020:362-364.

  21. Flanagan AM, Bridge JA, O’Donnell PG. Secondary osteosarcoma. In: WHO Classification of Tumours Editorial Board, ed. WHO Classification of Tumours of Soft Tissue and Bone. 5th Lyon, France: IARC Press; 2020:419-421.

  22. Tsuchiya KD, Tafe LJ, Bridge JAFISH testing of cytology specimens:pre-analytic, analytic and post-analytic considerations. In: Roy-Chowdhuri S, VanderLaan PA, Stewart JM, da Cunha Santos G. Molecular Diagnostics in Cytopathology : A Practical Handbook for the Practicing Pathologist. Cham, Switzerland: Springer International; 2019:127-159.

  23. Tsuchiya K, Tafe L, Bridge JA. Fluoresence in situ hybridization practices in cytopathology. In: Roy-Chowdhuri S, VanderLaan PA, Stewart JM, da Cunha Santos G. Molecular Diagnostics in Cytopathology : A Practical Handbook for the Practicing Pathologist. Lewiston, ME: SPi Global; 2018.

  24. Bridge JA and Nelson M. Genetics of soft tissue tumors. In: M. Miettinen, ed. Modern Soft Tissue Pathology: Tumors and Non-Neoplastic Conditions. 2nd Cambridge, UK: Cambridge University Press; 2016.

  25. Bridge JA, Mertens F. Tumour syndromes: introduction. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, F. Mertens, eds. WHO Classification of Tumours of Soft Tissue and Bone. 4th Lyon, France: IARC Press; 2013:368-371.

  26. Rosenblum AE, Bridge JA. Lipoma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, F. Mertens, eds. WHO Classification of Tumours of Soft Tissue and Bone. 4th Lyon, France: IARC Press; 2013:341.

  27. De Andrea CE, Bridge JA, Schiller A. Osteoblastoma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, F. Mertens, eds. WHO Classification of Tumours of Soft Tissue and Bone. 4th Lyon, France: IARC Press; 2013:279-280.

  28. Sciot R, Bridge JA. Synovial chondromatosis. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, F. Mertens, eds. WHO Classification of Tumours of Soft Tissue and Bone. 4th Lyon, France: IARC Press; 2013:261.

  29. Romeo S, Aigner T, Bridge JA. Chondromyxoid fibroma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, F. Mertens, eds. WHO Classification of Tumours of Soft Tissue and Bone. 4th Lyon, France: IARC Press; 2013:255-256.

  30. Lucas DR, Bridge JA. Chondromas: enchondroma, periosteal chondroma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, F. Mertens, eds. WHO Classification of Tumours of Soft Tissue and Bone. 4th Lyon, France: IARC Press; 2013:252-254.

  31. Fetsch JF, Bridge JA. Deep (“aggressive”) angiomyxoma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, F. Mertens, eds. WHO Classification of Tumours of Soft Tissue and Bone. 4th Lyon, France: IARC Press; 2013:198-199.

  32. Weiss SW, Antonescu CR, Bridge JA, Deyrup AT. Epithelioid haemangioendothelioma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, F. Mertens, eds. WHO Classification of Tumours of Soft Tissue and Bone. 4th Lyon, France: IARC Press; 2013:155-156.

  33. Mentzel T, Bridge JA. Myopericytoma, including myofibroma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, F. Mertens, eds. WHO Classification of Tumours of Soft Tissue and Bone. 4th Lyon, France: IARC Press; 2013:118-120.

  34. Fletcher CDM, Bridge JA, Lee J-C. Extrapleural solitary fibrous tumour. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, F. Mertens, eds. WHO Classification of Tumours of Soft Tissue and Bone. 4th Lyon, France: IARC Press; 2013:80-82.

  35. Miettinen MM, Bridge JA, Fetsch JF. Desmoplastic fibroma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, F. Mertens, eds. WHO Classification of Tumours of Soft Tissue and Bone. 4th Lyon, France: IARC Press; 2013:60-61.

  36. Lazar A, Bridge JA, Evans HL. Proliferative fasciitis and proliferative myositis. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, F. Mertens, eds. WHO Classification of Tumours of Soft Tissue and Bone. 4th Lyon, France: IARC Press; 2013:48-49.

  37. Kindblom L-G, Bridge JA, Meis JM. Chondroid lipoma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, F. Mertens, eds. WHO Classification of Tumours of Soft Tissue and Bone. 4th Lyon, France: IARC Press; 2013:28-29.

  38. Bridge JA and Nelson M. Genetics of soft tissue tumors. In: M. Miettinen, ed. Modern Soft Tissue Pathology: Tumors and Non-Neoplastic Conditions. Cambridge, UK: Cambridge University Press; 2010.

  39. Kalil R, Bridge JA. Small cell osteosarcoma. In: Fletcher C, Unni K, Mertens F, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:273-274.

  40. Rosenberg A, Bridge JA. Lipoma of bone. In: Fletcher C, Unni K, Mertens F, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:328-329.

  41. Weiss S, Bridge JA. Epithelioid Hemangioendothelioma. In: Fletcher C, Unni K, Mertens F, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:173-175.

  42. Evans H, Bridge JA. Proliferative Fasciitis and Proliferative Myositis. In: Fletcher C, Unni K, Mertens F, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:50-51.

  43. Evans H, Bridge JA. Nodular Fasciitis. In: Fletcher C, Unni K, Mertens F, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:48-49.

  44. Fornasier V, Pritzker K, Bridge JA. Desmoplastic fibroma. In: Fletcher C, Unni K, Mertens F, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002.

  45. Ostrowski M, Spjut H, Bridge JA. Chondromyxoid fibroma. In: Fletcher C, Unni K, Mertens F, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:242-245.

  46. Kilpatrick S, Parisien M, Bridge JA. Chondroblastoma. In: Fletcher C, Unni K, Mertens F, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:242-245.

  47. Guillou L, Bridge JA. Giant Cell Angiofibroma. In: Fletcher C, Unni K, Mertens F, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:79-80.

  48. McMenamin ME, Bridge JA. Mammary-type myofibroblastoma. In: Fletcher C, Unni K, Mertens F, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:242-245.

  49. Miettinen M, Bridge JA. Desmoplastic fibroblastoma. In: Fletcher C, Unni K, Mertens F, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:242-245.

  50. Farshid G, Bridge JA. Fibroma of tendon sheath. In: Fletcher C, Unni K, Mertens F, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:66.

  51. Rubin BP, Bridge JA. Myofibroma/Myofibromatosis. In: Fletcher C, Unni K, Mertens F, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:59-61.

  52. Hashimoto H, Bridge JA. Elastofibroma. In: Fletcher C, Unni K, Mertens F, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:56-57.

  53. Lucas D, Bauer T, Bridge JA. Chondromas: Enchondroma, periosteal chondroma, and enchondromatosis. In: Fletcher C, Unni K, Mertens F, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:237-240.

  54. Bridge JA, Schwartz HS, Neff JR. Sarcomas in bone. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, eds. Clinical Oncology. 2nd New York: Churchill Livingstone; 2000:2160-2272.

  55. Bridge JA, Orndal C. Cytogenetic analysis of bone and joint neoplasms. In: Helliwell T, ed. Pathology of Bone and Joint Neoplasms. Philadelphia, PA: Saunders; 1999:59-78.

  56. Bridge JA. Soft tissue sarcomas. In: Wolman SR and Sells, eds. Human Cytogenetic Cancer Markers. Totowa, NJ: Humana Press; 1997:425-459.

  57. Bridge JA, Persons D. Cytogenetics. In: Jacobs DS, Dermott WR, Grady HJ, Horvat RT, Huestis DW, Kasten Jr BL, eds. Laboratory Test Handbook: Concise, with Disease Index. 4th ed. Hudson, OH: Lexi-Comp: 1996.

  58. Bridge JA, Persons D. Cytogenetics. In: Jacobs DS, Dermott WR, Grady HJ, Horvat RT, Huestis DW, Kasten Jr BL, eds. Laboratory Test Handbook. 4th ed. Hudson, OH: Lexi-Comp: 1996:271-284.

  59. Bridge JA, Sandberg AA. Cytogenetics. In: Damjanov I and Linder J, eds. Andersons Pathology. Philadelphia, PA: Mosby Year Book; 1995: 223-257.

  60. Bridge JA, Schwartz HS, Neff JR. Sarcomas in bone. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, eds. Clinical Oncology. 1st ed. New York: Churchill Livingstone; 1995:1715-1797.

Books

  1. WHO Classification of Tumours Editorial Board, ed. Soft Tissue and Bone Tumours. 5th Lyon, France: IARC Press; 2020. WHO Classification of Tumours; vol 3.

  2. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. 4th Lyon, France: IARC Press; 2013.

  3. Unni KK, Inward CY, Bridge JA, Kindblom L-G, Wold LE. Tumors of the Bones and Joints. AFIP Atlas of Tumor Pathology; series 4, fascicle 2. Washington, DC: American Registry of Pathology Press; 2005.

  4. Bridge JA, Sanger WG. Genetics of Non-Hodgkin’s Lymphoma [Monograph]. Downers Grove, IL: Vysis, Inc.

  5. Sandberg AA and Bridge JAThe Cytogenetics of Bone and Soft Tissue Tumors. Austin, TX: R.G. Landes Co.; 1994.

Abstracts

  1. Rutland CD, Kingsley LG, Wang A, Das I, Bridge JA, Bishop JA, Krings G, Chen YY, Bean GR. Detection of CRTC1/3::MAML2 fusion using a novel BaseScope in situ hybridization assay for the diagnoses of mucoepidermoid carcinoma and hidradenoma [abstract 207]. USCAP Meeting, Baltimore, MD, March 23-28, 2024. Lab Invest. 2024;104(3)(suppl 1):S249.
      
  2. Zhang Y, Fanburg-Smith JC, Corey ZM, Bridge JA, Michal M, Murphey MD, Horvai A. EWSR1::NFATC2 fusion occurs in a subset of round cell, cystic, and vascular-rich tumors of bone [abstract 81]. USCAP Meeting, Baltimore, MD, March 23-28, 2024. Lab Invest. 2024;104(3)(suppl 1):S91-S92.
      
  3. Furlan K, Bridge JA, Tabbara SO, Wenig BM, Hernandez-Prera JC. Mesenchymal neoplasms of the head and neck: a study with emphasis on emerging entities and novel and unexpected fusions [abstract 1051]. USCAP Meeting, Baltimore, MD, March 23-28, 2024. Lab Invest. 2024;104(3)(suppl 1):S1307-S1308.
      
  4. Collins K, Bridge JA, Mehra R, Mannan R, Dickson BC, Idrees MT, Ulbright TM, Acosta AM. Renal epithelioid angiomyolipomas overexpress TFE3 and TFE3-mediated genes (TRIM63) in the absence of TFE3 rearrangement [abstract 735]. USCAP Meeting, Baltimore, MD, March 23-28, 2024. Lab Invest. 2024;104(3)(suppl 1):S924-S925.
      
  5. Acosta AM, Fletcher CDM, van Leenders GJLH, Oliva E, Cornejo KM, Collins K, Idrees MT, Hirsch MS, Ulbright TM, Bridge JA. Fluorescence in-situ hybridization demonstrates recurrent chromosomal gains in different types of testicular sex cord stromal tumors with pure or prominent spindle cell components [abstract 708]. USCAP Meeting, Baltimore, MD, March 23-28, 2024. Lab Invest. 2024;104(3)(suppl 1):S895.

  6. Amin SE, Bridge JA, Bishop JA, Naik U, Ahmed A, Saluja K. DEK::AFF2 fusion-associated sinonasal carcinoma: a challenging entity mimicking sinonasal papilloma. American Society of Dermatopathology, Chicago, IL, October 5-8, 2023.

  7. Shah S, Eapen P, Bridge JA, Gardner JM. Epihelioid fibrous histiocytoma with storiform spindle cells and pigmented dendritic melanocytes: a mimic of pigmented dermatofibrosarcoma protuberans (Bednar tumor). American Society of Dermatopathology, Chicago, IL, October 5-8, 2023.

  8. Smith F, Mezzacappa F, Zhang W, Gard A, Cabuk FK, Gonzalez-Gomez I, Liang JC, Pratt D, Quezado MM, Aldape KD, Bridge JA, Chen J. Potential prognostic determinants for FET::CREB positive intracranial mesenchymal tumor. USCAP Meeting, New Orleans, LA, March 11-16, 2023.

  9. Palsgrove DN, Rooper LM, Buresh CJ, Bishop JA, Bridge JA. AFF2 immunohistochemistry - a promising surrogate marker for DEK::AFF2 fusion-associated carcinoma. USCAP Meeting, New Orleans, LA, March 11-16, 2023.

  10. Wagner A, Akkari Y, Arbesfeld J, Baudis M, Baughn L, Bridge JA, Campregher P, Ceccarelli M, Clark KJ, Freimuth R, Horak P, Kuzma K, Lee K, Lee J, Li M, Liu J, Liu X, Myrand S, Roy A, Saliba J, Satgunaseelan L, Sboner A, Sonkin D, Stenzinger A, Stevenson J, Tanska A, Toruner G, Tsuchiya K, Vlachos I, Xu H, Xu X, Zhang L, Zou Y, Raca G. A unified framework for gene fusion representation. Cancer Genetics. 2022;268(Suppl 1):7. ISSN 2210-7762. https://doi.org/10.1016/j.cancergen.2022.10.023.

  11. Hosler CR, DiMaio  D, Lauer S, McGarry S, Bridge JA. First report of EWSR1::CREM1 fusion in cutaneous clear cell sarcoma. International Society of Dermatopathology, March 23-24, 2022.

  12. Rottmann D, Bridge JA, Linos K, Gross J, Reith J, Kilpatrick S, Torres-Mora J, Patel RM, Lucas D, Lauer S. Pseudomyogenic hemangioendothelioma of bone: a case series with uncommon FOSB fusions [abstract 1800]. USCAP Annual Meeting, Los Angeles, CA, March 19-24, 2022.

  13. Patton A, Bridge JA, Iwenofu OH. A YAP1-TFE3 cutaneous low-grade fibromyxoid neoplasm: a novel entity! American Society of Dermatopathology, Virtual, 2021.

  14. Velázquez Vega JE, Janss AJ, Boydston WR, Bridge JA, Snuderl M, Schniederjan MJ. Cervicomedullary astroblastoma with EWSR1-BEND2 fusion: expanding the molecular heterogeneity of astroblastomas and the HGNET-MN1 methylation class family. USCAP Annual Meeting, Virtual, 2021.

  15. Kerr DA, Thompson LDR, Tafe LJ , Jo VY,  Neyaz A, John I, Claudia M. Salgado CM, Vikram Deshpande V, Bridge JA, Brcic I, Linos KD. Expanding the clinicopathologic and genomic characterization of inflammatory myofibroblastic tumors of the head and neck: identification of a novel fusion partner and a potential diagnostic pitfall. USCAP Annual Meeting, Los Angeles, CA, March 2, 2020.

  16. Jia Y, Lu MV, Bridge JA. Malignant gastrointestinal neuroectodermal tumor of 49-year-old patient with remote history of lymphoma. CAP Annual Meeting, 2019. Arch Pathol Lab Med. 2019;43 (9):e5-6.

  17. Gatalica Z (Primary presenter), Swensen J, Stevens T, Brandwein-Weber M, Xiu J, Miettinen M, Bridge JA. NUTM1 gene rearranged neoplasia. USCAP Annual Meeting, Vancouver, Canada, March 2018.

  18. Zhu G, Benayed R, Hwang S, Agaram N, Bridge JA, Hameed M. Myositis ossificans-like aneurysmal bone cyst (MO-like ABC) :A clinicopathological and molecular analysis USCAP Annual Meeting, Vancouver, Canada, March 2018.

  19. Mintline M, Smith M, Fitzpatrick S, Patel P, Kessler, H McNamara K, Bilodeau E, Seethala R, Cohen D, Bridge JA, Reith J. USP6 gene rearrangement testing of gnathic aneurysmal bone cysts: a multicenter analysis of ten cases [presentation]. American American Academy of Oral & Maxillofacial Pathology, June 22-29, 2018.

  20. Gross JM, Abosolo P, Perry D, BedrnicekJ, Bridge JA. Primary synovial sarcoma of the anterior mediastinum: a rare twist of the “4 Terrible Ts” of anterior mediastinal masses. CAP Annual Meeting, March 17, 2018.

  21. Pfederer N. Gross JM, Bridge JA, Nguyen C, Ruma T. Primary intra-axial central nervous system inflammatory myofibroblastic tumor, ALK negative: a rare entity. CAP Annual Meeting March 17, 2018.

  22. Zhang H, Saharti S, Bridge JA, Saad AG. Identification of a novel NRAS mutation in a sporadic pyogenic granuloma; implications for diagnosis and therapy. 2nd Pediatric Precision Oncology Conference, Scottsdale, AZ, March 2-4, 2018.

  23. Saharti S, Zhang H, Laetsch TW, Roy A, XU, L, Black J, Coffin CM, Chin YY, Tian J, Spundt SL, Hawksin DS, Partsons W, Skapek SX, Bridge JA. detection of clinically relevant copy number alterations and oncogenic fusion genes in childhood undifferentiated sarcoma: a report from the Children’s Oncology Group. 2nd Pediatric Precision Oncology Conference, Scottsdale, AZ, March 2-4, 2018.

  24. Mintine M, Bridge JA, Reith J. USP6 gene rearrangement testing of gnathic aneurysmal bone cysts: a multicenter analysis of ten cases. IAOP-AAOMP Joint Meeting, Chicago, IL, April 20, 2018.

  25. Pflederer N, Gross JM, Bridge JA, Ruma T. Primary intra-axial central nervous system inflammatory myofibroblastic tumor, ALK negative: a rare entity. Society for NeuroOncology 23rd Annual Meeting and Education Day, New Orleans, LA, Nov15-18, 2018.

  26. Gross J, Bridge JA, Bedrniak J, Abasolo P. Perry D. Primary synovial sarcoma of the anterior mediastinum: a rare twist on the “4 Terrible Ts” of anterior mediastinal masses. CAP18 The Pathologists Meeting, October 23, 2018. Arch of Path Lab Med. 2018.

  27. Laetsch TW, Roy A, Xu L, Black JO, Coffin, CM, Chi YY, Spunt SL, Hawkins DS, Bridge JA, Parsons DW, Skapek SX. Undifferentiated sarcomas harbor frequent oncogenic fusions and prognostic copy number alterations: a report from the Children’s Oncology Group (COG) Soft Tissue Sarcoma Committee. AACR Annual Meeting, December 2017.

  28. Calleroz AT, Lowas SR, Yuan J, Bridge JA, McGarry SV, Kozel JA. Ewing sarcoma as a secondary malignant neoplasm following B-cell acute lymphoblastic leukemia in a pediatric patient. CAP Annual Meeting, Las Vegas, NV, 2016.

  29. Greiner T, PlambeckJ, Cushman-Vokoun A, Bridge JA; Zhang W . NGS sequence data with too few reads for adequate analysis may reflect the presence of an amplified gene consuming reagents rather than poor quality DNA. J Mol Diag. 2016.

  30. Rimm DL, Han G, Taube JM, Yi J, Bridge JA, MD, Flieder D, Homer R,West W, Wu H, Roden A, Fujimoto J, Boyle T, Anders  R, Kowalewski A,  Rivard C, Rehman J, M, Hirsch F, Wistuba I. A prospective, multi-institutional assessment of four assays for PD-L1 expression in non-small cell lung carcinoma (NSCLC) by immunohistochemistry.  J Thorac Oncol. November 2016.

  31. Plambeck J, Cushman-Vokoun A, Zhang W, Bridge JA, Greiner TC. MET and ERBB2 amplification. Association for Molecular Pathology Meeting, Charlotte, NC, November 10-12, 2016.

  32. Zheng W, Lawrence C, Bridge JA, Yu Z. A case of intrapelvic lipoblastoma mimicking myxoid liposarcoma with pleomorphic adenoma gene 1 rearrangement confirmed by fluorescence in situ hybridization. CAP Meeting, 2015.

  33. Calleroz A, Liu X-Q, Zhang Y, Drinkall L, Bridge JA. Preclinical validation of PLAG1 fluorescence in situ hybridization assay as an ancillary tool in the differential diagnosis of lipomatous neoplasms. American Society for Clinical Pathology Annual Meeting, October 28-30, 2015.

  34. Zorta V, Seigel G, Bridge JA, Bui M. Utility of PRKCB immunohistochemical stain in fine needle aspiration biopsies, core biopsies and resection specimens in diagnosis of Ewings Sarcoma. American Society of Cytopathology Annual Meeting, July 2015.

  35. Zheng W, Yu Z, Bridge JA, Lawrence C. A case of intrapelvic lipoblastoma mimicking myxoid liposarcoma with pleomorphic adenoma gene 1 rearrangement confirmed by fluorescence in situ hybridization. CAP Annual Meeting, October 2015.

  36. Calleroz A, Bridge JA. Preclinical Validation of PLAG1 fluorescence in situ hybridization assay as an ancillary tool in the differential diagnosis of lipomatous neoplasms. ASCP Annual Meeting, Long Beach, CA, October 2015.

  37. Duncavage E, Abel H, Merker J, Bodner H, Voelkerding K, Bridge JA, Pfeifer J. A model study of in silico proficiency testing for clinical next generation sequencing. October 2015.

  38. Wallace E, Lai EW, Mach K, Haque N, McCann L, Hsiao S, Bui D, Mohan R, Satya M, Wong E, Bridge JA, Persing D, Higuchi R, Liao J. Development of urine-based multiplex molecular assay for bladder cancer diagnosis. European Urology Supplements. 2014;13(1):e628.

  39. Deal T, Bridge JA, Wong A, McKay K. Angiofibroma of soft tissue: A recently characterized entity with emphasis on molecular findings and differential diagnosis. 17th Joint Meeting of The International Society of Dermatopathology Meeting, 2014.

  40. Wedel WR, Horn AJ, Mukherjee M, Bridge JA, McGaughey M, Donnelly A, Lyden E, Meza J, Radio SJ. Evaluating diagnostic concordance of 3-d virtual gynecologic imaging vs. light microscopy: follow-up study. Mod Pathol. 2013;26(2):107A.

  41. Liu L, LaGrange, Liu X, Zhang Y, Zhang H, Huang D, Greiner, Bridge JA, Lele SM. Uterine leiomyomata with bizarre nuclei: expression of p53 and P16ink4 is common; however, mutations of TP53 are rare and may be associated with hereditary leiomyomatosis and renal cell carcinoma syndrome. Mod Pathol. 2013;26(2):287A.

  42. Wallace E, Lai EW, Mach KE, Haque N, McCann L, Hsiao S, Bui D, Mohan R, Satya M, Wong E, Bridge JA, Persing D, Higuchi R, Liao JC. Multiplex detection of urinary biomarkers for rapid bladder cancer diagnosis using an automated cartridge-based platform. American Association for Cancer Research, Washington, DC, April 6-10, 2013.

  43. MacQuarrie E, Organ M, Bridge JA, Lawen J, Merrimen J, Dakin Hache K. Primary renal Ewings sarcoma/primative neuroectodermal tumor with a rare fusion transcript in an adult patient. Canadian Association of Pathologists, Québec City, Canada, June 8-12, 2013.

  44. Garabedian E, Phan G, Cowan E, Kong H, Bridge JA, Lee C, Pittaluga S, Baird K, Adams W. Role of surgical resection in multicentric dermatofibrosarcoma protuberans in children with adenosine deaminize-deficient severe combined immune deficiency. World Congress of Pediatric Surgery Meeting, 2013.

  45. Wallace E, Lai EW, Mach KE, Haque N, McCann L, Hsiao S, Bui D, Mohan R, Satya M, Wong E, Bridge JA, Persing D, Higuchi R, Liao JC. Multiplex detection of urinary biomarkers for rapid bladder cancer diagnosis using an automated cartridge-based platform. Cancer Research. 2013;73(8 Supplement):LB-84-LB-84.

  46. Demicco EG, Wang W-L, Bridge JA, Huang D, Madewell JE, Meis JM. Extraskeletal myxoid chondrosarcoma presenting as a primary bone tumor: four cases with molecular confirmation. USCAP Annual Scientific Meeting, Vancouver, Canada, March 17-23, 2012.

  47. Bowen JM, Radio SJ, Huang D, Hutchins G, Bridge JA. FISH and KRAS mutation testing as adjuncts to biliary brushing cytology for the detection of pancreatobiliary tract malignancy. USCAP Annual Scientific Meeting, Vancouver, British Columbia, Canada, March 17-23, 2012.

  48. Skapek SX, Anderson J, Barr F, Bridge JA, Gastier-Foster J, Parham D, Rudzinski E, Triche T, Hawkins D. Relationship of fusion protein status and outcome for children with intermediate risk rhabdomyosarcoma. ASCO Annual Meeting, Chicago, IL, June 1-5, 2012. J Clin Oncol. June 2012.

  49. Bridge JA, Zhang Y, Correa H, Cajaiba M, Dickman P, Saad A, Fletcher CDM, Perry D. Use of a Novel FISH Assay as an Adjunct to Diagnosis of Lipoblastoma. AMP Annual Meeting on Genomic Medicine, Long Beach, CA, October 25-27, 2012.

  50. Wang L, Motoi T, Khanin R, Socci N, Olshen A, Mertens F, Bridge JA, Dal Cin P, Rushing EJ, Fanburg-Smith J, Antonescu C, Hameed M, Ladanyi M. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. USCAP Annual Scientific Meeting, San Antonio, TX, February 26-March 4, 2011. Mod Pathol. 2011;23:23A.

  51. Lyle PL, Simpson JF, Bridge JA, Cates JM, Page DL, Sanders ME. Mammary liposarcoma: a clinicopathologic and molecular analysis. USCAP Annual Scientific Meeting, San Antonio, TX, February 26-March 4, 2011. Mod Pathol. 2011;23:53A.

  52. Radio SJ, Zhang Y, Huang D, Neff R, Bridge JA. Analysis of the PRKARIA gene locus in sporadic cardiac myxomas. USCAP Annual Scientific Meeting, San Antonio, TX, February 26-March 4, 2011. Mod Pathol. 2011;23:78A.

  53. Neff RE, Zhang Y, Huang D, Liu, X-Q, Bridge JA. Loss of the PRKAR1A gene locus identified by conventional cytogenetic and fluorescence in situ hybridization analysis in solitary superficial angiomyoma. USCAP Annual Scientific Meeting, San Antonio, TX, February 26-March 4, 2011. Mod Pathol. 2011;23:121A.

  54. Debelenko L, Raimondi S, Daw N, Shivakumar B, Nelson M, Huang D, Bridge JA. Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum. USCAP Annual Scientific Meeting, San Antonio, TX, February 26-March 4, 2011. Mod Pathol. 2011;23:187A.

  55. Huang D, Bridge JA. Use of a novel FISH assay as a diagnostic adjunct for extraskeletal myxoid chondrosarcoma. USCAP Annual Scientific Meeting, San Antonio, TX, February 26-March 4, 2011. Mod Pathol. 2011;23:450A.

  56. DH, Wing MR, Kneile K, Moyer Y, Anderson JR, Barr FG, Bridge JA, Buckley JD, Seeger RC, Pyatt RE, Gastier-Foster JM, Hawkins DS, Skapek SX, Triche TJ. Translating diagnostic gene expression profiles for pediatric solid tumors. AACR Annual Meeting, Orlando, FL, April 2-6, 2011.

  57. Bridge JA, Streblow R, Frayer RW, Dal Cin P, Rosenberg A, Meloni-Ehrig A, Sumegi J. Recurrent (2;2) and (2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator (NCOA) family. USCAP Meeting, Washington, DC, March 2010. Mod Pathol. 2010;23:16A.

  58. Romeo S, Duim RAJ, Bridge JA, Mertens F, De Jong D, Dal Cin P, Wijers-Koster PM, Debiec-Rychter M, Sciot R, Rosenberg A, Szuhai K, Hogendoorn PCW. Heterogeneous and complex rearrangements of the long arm of chromosome 6q in chondromyxoid fibroma. USCAP Meeting, Washington, DC, March 2010. Mod Pathol. 2010;23:27A.

  59. McComb RD, Bruch LA, Reyes CA, Puccioni MJ, Bridge JA. Novel translocation t(9;17)(q32;q24) in a glioneuronal tumor. USCAP Meeting, Washington, DC, March 2010. Mod Pathol. 2010;23:378A.

  60. Shatat L, Bridge JA, Gatalica Z, Hagenkord JM. Genomic Characterization of Peritoneal Mesothelioma Reveals Recurrent Loss of 6, 9, and 22 Chromosomal Material. USCAP Meeting, Washington, DC, March 2010. Mod Pathol. 2010;23:428A.

  61. Dumont SN, Lazar AJF, Bridge JA, Trent, JC. PAX3/7-FKHR translocation by fluorescent in situ hybridization (FISH) using an adult rhabdomyosarcoma tissue microarray. American Society of Clinical Oncology, Chicago, IL, June 2010.

  62. Riddle, ND, Gonzalez, RJ, Bridge JA, Antonia S, Bui MM. A CD117 and CD34 immunoreactive sarcoma masquerading as gastrointestinal stromal tumor and literature review of diagnostic pitfalls of ancillary studies in sarcoma. Arch Pathol Lab Med. 2010;134(9):1350.

  63. Mast K, Goody S, Bridge JA, Wushensky C, Cates J, Correa H, Carell Jr. M. Chondroblastoma of the maxilla in a 14-year old girl. Society for Pediatric Pathology, Banff, Alberta, Canada, September 2010.

  64. Kesserwan C, Sokolic R, Jagadeesh J, Cowen E, Baird K, Wayne A, Garabedian E, Pittaluga S, Lee R, Sherry R, Bridge JA, Cohen J, Finlayson L, Walsh N, Issekutz A, Condotti F. Multicentric DFSP in a patient with ADA-SCID: unique association with atypical histology and therapeutic challenge. USCAP Annual Scientific Meeting, Boston, MA, March 7-13, 2009.

  65. Kim HJ, Shen SS, Truong LD, Ro JY, Ayala AG, Alvarez K, Gatalica Z, Bridge JA, Monzon FA. Virtual-karyotyping with SNP Arrays is a useful approach for the diagnosis of morphologically difficult renal cell neoplasms. USCAP Annual Scientific Meeting, Boston, MA, March 7-13, 2009. Mod Pathol. 2009;22:372A.

  66. Huang D, Sumegi J, Reith JD, Dal Cin P, Yasuda T, Nelson, M, Bridge JA. MGC3032-MKL2 is the resulting fusion oncogene of t(11;16)(q13;p13) in chondroid lipoma. USCAP Annual Scientific Meeting, Boston, MA, March 7-13, 2009. Mod Pathol. 2009;22:14A.

  67. Streblow R, Perry K, Miettinen M, Alaggio R, Coffin CM, Folpe AL, Nelson M, Dafferner A, Woodard J, Yeh K, Bridge JA. Translocations 12;16 and 12;22 in pediatric myxoid/round cell liposarcoma: prevalence and distribution. USCAP Annual Scientific Meeting, Boston, MA, March 7-13, 2009. Mod Pathol. 2009;22:22A.

  68. Yasuda T, Nishio J, Kapels KM, Althof PA, Sawyer JR, Reith JD, Bridge JA. Cytogenetic and molecular cytogenetic findings in chondromyxoid fibroma: aberrations of 6q13 mapped to the COL12A1 locus by fluorescence in situ hybridization. USCAP Annual Scientific Meeting, Boston, MA, March 7-13, 2009. Mod Pathol. 2009;22:25A.

  69. Messerwan C, Sokolic R, Cowen E, Garabedian E, Pittaluga S, Baird K, Lopez-Terrada D, Bridge JA, Wayne A, Candotti F, Sherry R, Heselmeyer K, Lee R, Finlayson L, Walsh N, Patel K, Ortiz C. Dermatofibrosarcoma protuberans (DFSP) in 6 Patients with ADA-SCID [abstract 10570]. American Society of Clinical Oncology Annual Meeting, Orlando, FL, May 29-June 2, 2009. J Clin Oncol. 2009;27:15s.

  70. Cowan EW, Kesserwan C, Sokolic R, Garabedian E, Baird K, Wayne A, Pittaluga S, Lopez-Terrada D, Bridge JA, Condotti F. Multiple dermatofibrosarcoma protuberans (DFSP) in patients with ADA-SCID. NIH for the Society for Investigative Dermatology, May 2009. J Invest Dermatol. 2009;129.

  71. Greiner, TC, Bridge JA, Herrera V, Gebhart C. Performance of Pyromark KRAS V.2.0 mutation detection kit in paraffin embedded tissues pryomark q24. Association for Molecular Pathology, Orlando, FL, November 2009. J Mol Diagn. 2009;11(6):650.

  72. Bridge JA, Nishio J, Nelson M, Perry D, Sumegi J. A novel translocation t(4;22)(q31;q12) produces an in-frame fusion of EWSR1 and SMARCA5 in peripheral primitive neuroectodermal tumor. Association for Molecular Pathology, Orlando, FL, November 2009. J Mol Diagn. 2009;11(6):667.

  73. Shatat L, Bridge JA, Gatalica Z, Hagenkord JM. Genomic characterization of peritoneal mesothelioma reveals recurrent loss of 6, 9, and 22 chromosomal material. J Mol Diagn. 2009;11(6).

  74. Nelson M., Perkinns SL, Coccia, PF, Bridge JA, Dave BJ, Sanger WG. Rearrangement in children and adolescents with Burkitt lymphoma. Frequency of 13q deletion and MYC. Association of Genetic Technologists Annual Meeting, 2009.

  75. Althof P, Nelson M, Keenportz B, Persiidski L, Sanger WG, Bridge JA, Cytogenetic abnormalities in a case of malignant pecoma arising in the retroperitoneum. Association of Genetic Technologists Annual Meeting, 2009.

  76. Peck HR, Nelson M, Pedeutour F, Gatalica Z, Miettinen M, Bridge JA. Use of a novel FISH assay as an adjunct to diagnosis of dermatofibrosarcoma protuberans and giant cell fibroblastoma [abstract 1678]. USCAP Meeting, Denver, CO, March 1-7, 2008. Mod Pathol. 2008;21(S1):368A.

  77. Perry K, Nelson M, Nassir A, Bui M, Goldschmidt R, Gnepp D, Bridge JA. Alveolar rhabdomyosarcoma of the head and neck region in older adults [abstract 64]. USCAP Meeting, Denver, CO, March 1-7, 2008. Mod Pathol. 2008;21(S1):17A.

  78. Monzon FA, Gatalica Z, Bridge JA, Alvarez K, Kim HJ, Hagenkord JM. Detection of chromosomal aberrations in renal tumors: a comparative study of conventional cytogenetics and SNP microarrays. Association of Molecular Pathology, Grapevine, TX, October 2-November 2, 2008.

  79. Kesserwan C, Sokolic R, Heselmeyer K, Ortiz C, Cohen J, Jagadeesh J, Pittalugua S, Garabedian E, Baird K, Wayne A, Cohen E, Lee R, Cherry R, Bridge JA, Issekutz A, Candotti F. Dermato-fibrosarcoma protuberans in 3 patients with ADA-SCID. American Society of Hematology, 2008.

  80. Qualman S, Lynch J, Bridge JA, Parham DP, Teot L, Meyer W, Pappo A. Prospective evaluation of anaplasia and its significance in rhabdomyosarcoma. Mod Pathol. 2006;19:324.

  81. Nishio J, Gentry JD, Neff JR, Nelson M, Daniels W, Perry D, Gatalica Z, Bridge JA. Monoallelic deletion of the p53 gene through chromosomal translocation in a small cell osteosarcoma. Pediatric Research Forum, Childrens Hospital, Omaha, NE, May 12, 2006.

  82. Althof PA, Nelson ML, Persidskii I, Keenportz B, Sanger WS, Bridge JA. Cytogenetic abnormalities in a case of malignant PEComa arising in the retroperitoneum. Association of Genetic Technologists, Baltimore, MD, June 1-4, 2006.

  83. Nishio J, Neff JR, Dafferner AJ, Hartmann MM, Zhou M, Bridge JA. A comparison of fluorescence in situ hybridization (FISH) and cytogenetics for detection of CSF (1p13) rearrangements in tenosynovial giant cell tumors. Association for Molecular Pathology, Orlando, FL, November 16-19, 2006.

  84. Gatalica Z, McCue PA, Sharma P, Bridge JA, Knezetic J, Hempel J, Lilleberg S. Medullary renal carcinoma phenotype is associated with diverse genotypes. Association for Molecular Pathology Annual Meeting, Orlando, FL, November 16-19, 2006.

  85. Stevens R, Almanaseer I, Gonzalez M, Caglar D, Knudson RA, Ketterling RP, Bridge JA. Analysis of HER-2 gene amplification using an automated FISH signal enumeration system [abstract 223]. USCAP Meeting, San Antonio, TX, February 26-March 4, 2005. Mod Pathol. 2005:18(S1):51A.

  86. Oliveira AM, Perez-Atayde AR, Dal Cin P, Gebhardt MC, Rosenberg AE, Bridge JA, Fletcher JA. Novel USP6 fusion oncogenes with TRAP150, ZNF9, Osteomodulin, and COL1A1 in aneurysmal bone cyst variant translocations [abstract 73]. USCAP Meeting, San Antonio, TX, February 26-March 4, 2005. Mod Pathol. 18(S1):19A.

  87. Nishio J, Althof P, Bailey J, Zhou M, Neff JR, Barr F, Parham D, Qualman S, Bridge JA. Use of FISH on paraffn-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma (ARMS) [abstract 1413]. USCAP Meeting, San Antonio, TX, February 26-March 4, 2005. Mod Pathol.18(S1):305A.

  88. Ellison DA, Parham DM, Bridge JA, Beckwith JB. Immunohistochemical profiles of 30 Ewing’s sarcoma/peripheral neuroectodermal tumors of the kidney. Society for Pediatric Pathology, Little Rock, AR, November 2005.

  89. Stevens R, Almanaseer I, Gonzalez M, Caglar D, Knudson RA, Ketterling RP, Bridge JA. Analysis of HER-2 gene amplification using an automated FISH signal enumeration system [abstract 17]. Nebraska Research Expo, Nebraska EPSCoR, Omaha, NE, April 20, 2005.

  90. Hornaman KM, Abramowsky CR, Katzenstein HM, Wulkan ML, Bridge JA, Kenney BD, Shehata BM. Undifferentiated embryonal sarcoma (UES) of the liver: eight new cases with discussion of chromosomal abnormalities and selected cases associated with mesenchymal hamartoma (MH). Society for Pediatric Pathology/United States and Canadian Academy of Pathology (SPP/USCAP) Joint Meeting, Tours, France, August 31-September 3, 2005.

  91. Mathews K, Radio SJ, Jaksha J, Conces A, Bridge JA. Reverse transcription analysis of two primary synovial sarcomas of the heart. Eighth Annual Cardiovascular Research Symposium, University of Nebraska Medical Center, Omaha, NE, February 6, 2004.

  92. Althof PA, Ohmori K, Zhou M, Bailey JM, Bridge RS, Nelson M, Neff JR, Bridge JA. Cytogenetic and molecular cytogenetic findings in 43 aneurysmal bone cysts: aberrations of 17p mapped to 17p13.2 by fluorescence in situ hybridization [abstract 24]. USCAP Meeting, Vancouver, Canada, March 6-12, 2004. Mod Pathol. 2004;17(S1):9A.

  93. Argani P, Hutchinson B, Bridge JA, Reuter V, M Ladanyi. Aberrant Nuclear Immunoreactivity for TFEB is a specific marker of renal tumors bearing the t(6;11)(p21;q12) [abstract 1380]. USCAP Meeting, Vancouver, Canada, March 6-12, 2004. Mod Pathol. 2004;17(S1):328A.

  94. Bruch LA, Bridge RS, Neff JR, Naumann S, Althof P, Bridge JA. Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumor and malignant triton tumor: a cytogenetic and molecular cytogenetic study [abstract 1323]. USCAP Meeting, Vancouver, Canada, March 6-12, 2004. Mod Pathol. 2004;17(S1):315A.

  95. Abrahams NA, Balaji K, Nelson M, Bridge JA. Correlation of cytogenetic abnormalities in 41 consecutive cases of renal cell carcinoma: prognostic impact on grade and stage [abstract 557]. USCAP Meeting, Vancouver, Canada, March 6-12, 2004. Mod Pathol. 2004;17(S1):134A.

  96. Deyrup AT, Althof P, Zhou M, Solomon A, Bridge JA, Weiss SW. Paraganglioma-like dermal melanocytic tumor: a unique entity distinct from cellular blue nevus, clear cell sarcoma and cutaneous malignant melanoma [abstract 378]. USCAP Meeting, Vancouver, Canada, March 6-12, 2004. Mod Pathol. 2004;17(S1):92A.

  97. Oliveira AM, His B-L, Weremowicz S. Perez-Atayde AR, Rosenberg AE, Dal Cin P, Joseph N, Bridge JA, Fletcher JA. Translocation (16; 17)(q22;p13) fuses osteoblastic cadherin CDH11 to USP6 in aneurysmal bone cyst [abstract 61]. USCAP Meeting, Vancouver, Canada, March 6-12, 2004. Mod Pathol. 2004;17(S1):18A.

  98. Sarosdy MF, Bridge JA, Johansson SL, Lieber M, Schellhammer P, Soloway M. Positive fluorescent in situ hybridization (FISH) assay associated with negative cystoscopy for bladder cancer surveillance uniquely predicts tumor recurrence. American Urological Association Annual Meeting, San Francisco, CA, May 8-13, 2004.

  99. Mathews K, Johansson S, Miloro M, Sanger WG, Bridge JA. Cytogenetic finding of solitary myofibroma. Association of Genetic Technologists 29th Annual Meeting, Anaheim, CA, June 17-20, 2004.

  100. Ellison DA, Parham DP, Bridge JA, Beckwith JB. Immunohistochemical profiles of 30 Ewing’s sarcoma/peripheral neuroectodermal tumors of the kidney. Society of Pediatric Pathology Interim Meeting, Little Rock, AR, October 28-31, 2004.

  101. Bridge JA, Gentry JD, Swarts SJ, Billings SD, Bridge RS, Althof PA, Pickering D, Neff JR, Weiss SW. Supernumerary ring chromosomes in pleomorphic hyalinizing angiectatic tumor: a feature of potential diagnostic utility [abstract 26]. USCAP Meeting, Washington, DC, March 22-28, 2003. Mod Pathol. 2003;16(1):9A.

  102. Ma Z, Hill DA, Collins MH, Morris SW, Sumegi J, Zhou M, Zuppan C, Bridge JA. Fusion of ALK to the Ran-Binding Protein 2 (RanBP2) gene in inflammatory myofibroblastic tumor [abstract 1381]. USCAP Meeting, Washington, DC, March 22-28, 2003. Mod Pathol. 2003;16(1):302A.

  103. Bridge JA, Liu J, Qualman S, Suijkerbuijk R, Wenger G, Zhang J, Wan X, Baker KS, Sorensen P, Barr F. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. USCAP Meeting, Chicago, IL, February 25, 2002. Mod Pathol.

  104. Sorensen PHB, Lynch JC, Qualman SJ, Lim JF, Tirabosco R, Maurer H, Crist W, Bridge JA, Triche TJ, Barr FG. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma—an intergroup rhabdomyosarcoma study. American Society of Clinical Oncology Meeting, 2001.

  105. Sardosdy M, Schellhammer P, Kahn P, Yore L, Zadra J, Bridge JA, Johansson S, Anderson S, Flom K. Clinical evaluation of a multi-target fluorescent in-situ hybridization (FISH) assay for bladder cancer detection. American Urological Association Annual Meeting, Anaheim, CA, June 4, 2001.

  106. Bridge JA, Kanamori M, Ma Z, Pickering D, Hill DA, Lydiatt W, Lui MY, Colleoni GWB, Antonescu CR, Ladanyi M, Morris SW. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Connective Tissue Oncology Annual Meeting, Palm Beach, FL, November 1-3, 2001.

  107. Bridge JA, Kanamori M, Ma Z, Pickering D, Hill DA, Lydiatt W, Lui MY, Colleoni GWB, Antonescu CR, Ladanyi M, Morris SW. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in Inflammatory Myofibroblastic Tumor. Association for Molecular Pathology Meeting, Philadelphia PA, November 15-18, 2001. J Mol Diagn.

  108. Bridge JA, Liu J, Weibolt V, Baker KS, Perry D, Kruger R, Qualman S, Barr F, Sorensen P, Triche T, Suijkerbuijk R. Novel genomic imbalances in embryonal rhabdomyosarcoma. USCAP Annual Meeting, New Orleans, LA. Mod Pathol. 2000;13(1):203A.

  109. Lestou VS, O’Connell JX, Bridge JA, Sorensen PHB. Detection of a novel and common region of amplification at 19q13.1-q13.3 in malignant fibrous histiocytoma using CGH and FISH. Eighth International Workshop on Chromosomes in Solid Tumors, Tucson, AZ, January 30-February 1, 2000.

  110. Colleoni GWB, Garicochea B, Lui MY, Bridge JA, Filippa DA, Ladanyi M. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma. USCAP Annual Meeting, New Orleans, LA. Mod Pathol. 2000;13(1):145A.

  111. Liu J, Scott M, Nelson M, Hopkovitz A, Sanger W, Bridge JA. Pleomorphic rhabdomyosarcoma: cytogenetic and comparative genomic hybridization analysis. Association of Genetic Technologists, Scottsdale, AZ, June 22-25, 2000.

  112. Lestou VS, Bridge JA. Lestou VS, O’Connell J, Sorensen PHB. Non-random chromosomal amplification and breakage-fusion-bridge events establish the genetic complexity and heterogeneity of malignant fibrous histiocytoma. Tucson, AZ, 2000.

  113. Ladanyi M, Lui MY, Antonescu CR, Krause-Boehm A, Meindl A, Argani P, Healey JH, Ueda T, Yoshikawa H, Melon-Ehrig A, Sorensen PHB, Mertens F, Mandahl N, van den Berghe H, Sciot R, Dal Cin P, Bridge JA. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. American Society of Human Genetics Annual Meeting, 2000. Mod Pathol. 2001;14:14A.

  114. Ma A, Hill A, Collins M, Witte DP, Bridge JA, Ladanyi M, Cook JR, Dehner LP, Coffin C, Morris SW. ALK fusion genes in the pathogenesis of a non-hematopoietic malignancy – inflammatory myofibroblastic tumor (IMT). American Society of Hematology Meeting, San Francisco, CA, December 2000.

  115. Ladanyi M, Lui MY, Antonescu CR, Krause-Boehm A, Meindl A, Argani P, Healey JH, Ueda T,Yoshikawa H, Melon-Ehrig A, Sorensen PHB, Mertens F, Mandahl N, van den Berghe H, Sciot R, Dal Cin P, Bridge JA. Cloning of the der(17)t(X;17)(p11;q25) of alveolar soft part sarcoma identifies the ASPL-TFE3 gene fusion, a new molecular diagnostic marker. USCAP Meeting, Atlanta, GA, March 3-9, 2001.

  116. Breiner JA, Meis-Kindblom J, Kindblom L-G, Nelson M, Bridge JA. Loss of 14q and 22q in gastrointestinal pacemaker cell tumors (GIPACT). USCAP Annual Meeting, San Francisco, CA, March 20-26, 1999. Mod Pathol. 1999;12(1):72A.

  117. Lestou VS, Bridge JA, Squire J, Lim J, Sorensen PHB. Genomic imbalances in adult and pediatric malignant fibrous histiocytoma reveals both characteristic differences and similarities. SIOP: Societe Internationale D’Oncologie Pediatrique, Montreal, Canada, Sep. 13-18, 1999. (Official SIOP Journal) Medical & Pediatric Oncology. 1999;33(3):262.

  118. Rao VH, Singh RK, Finnell RH, Delimont D, Bridge JA, Neff JR, Wanger WG, Buehler BA, Schaefer GB. Activation of cAMP inhibits TNF-alpha induced MMP-9 (92-kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone. Proceedings of the American Association for Cancer Research. 1999;40:178.

  119. Zielenska M, Bridge JA, Bayani J, Pandita A, Marrano P, Thorner P, Sorensen P, Squire JA. CGH and SKY analysis identify consistent numerical and structural chromosomal changes in osteosarcoma. Proceedings of the American Association for Cancer Research. 1999;40:602.

  120. Krause Boehm A, Orndal C, Nelson M, McComb E, Neff J, Rubocki R, Bridge JA. Cytogenetic, molecular cytogenetic, and mutational analysis of 8q24.1 (EXT1) in 47 sporadic osteochondroma and chondrosarcoma specimens. American Society of Human Genetics (ASHG), San Francisco, CA, October 19-24, 1999.

  121. Colleoni GWB, Garicochea B, Lui MY, Bridge JA, Filippa DA, Ladanyi M. Evidence for additional variant ALK gene fusions in anaplastic large cell lymphoma (ALCL). American Society of Hematology (ASH) 41st Annual Meeting, New Orleans, LA, December 3-7, 1999.

  122. Bridge JA, Nelson M, Örndal C, Wells D, Neff JR. Anomalies of the hereditary multiple exostoses chromosomal loci (8q24.1 and 11p11-12) in sporadic osteochondromas. Mod Pathol. 1998;11:1P.

  123. Bridge JA, Fidler ME, Neff JR, Wang M, Degenhardt J, Walker C, Seemayer TA. Adamantinoma-like Ewing’s sarcoma. Mod Pathol. 1998;11:7A.

  124. Bridge JA, Baker KS, Weibolt V, Perry D, Kruger R, Qualman S, Barr F, Sorensen P, Triche T, Suijkerbuijk R. Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization: an intergroup rhabdomyosarcoma study (IRS). American Society of Clinical Oncology Program/Proceedings Annual Meeting. 1998;17:536A.

  125. Rao VH, Singh RK, Delimont DC, Bridge JA, Neff JR, Pickering DL, Sanger WG, Buehler BA, Schaefer GB. Interleukin-1ß upregulates the expression of gelatinase B (92-kDa type IV collagenase) in giant cell tumor of bone. AACR Annual Meeting, New Orleans, LA, March 28-April 1, 1998.

  126. Bridge JA, Nelson M, Örndal C, Bhatia P, Neff J. Clonal karyotypic Abnormalities of the hereditary multiple exostoses chromosomal loci 8q24.1 (EXT1) and 11p11-12 (EXT2) in sporadic and hereditary osteochondromas. J of Assoc of Genet Tech. 1998;24:15.

  127. Bridge JA, Fidler ME, Neff JR, Wang M, Degenhardt J, Walker C, Seemayer TA. Adamantinoma-like Ewing’s sarcoma [presentation]. 4th International Combined Meeting of the American and European Musculoskeletal Tumor Societies, Washington, DC, May 7-10, 1998.

  128. Schwartz H, Aue, G, Bridge JA, Neff JR, Butler M. Clear cell sarcoma: microsatellite instability and clinical correlation. Combined Meeting of the American and European Musculoskeletal Tumor Societies Abstract Book. 1998:120.

  129. Bridge JA, Neff JR, Fidler M, Degenhardt J, Wang M, Walker C, Dorman H, Baker KS, Seemayer T. Adamantinoma-like Ewings sarcoma: genomic confirmation, phenotypic drift. Combined Meeting of the American and European Musculoskeletal Tumor Societies Abstract Book. 1998:150.

  130. Bridge JA, Orndal C, Williamson JE, Miller-Lindholm AK, Neff JR. Mutational analysis of EXT1 in eight cytogenetically characterized sporadic osteochondromas. Orthop Transactions. 1997.

  131. Bridge JA, Swarts SJ, Degenhardt JM, Neff JR. Trisomy 8 characterizes a subgroup of benign fibrous lesions arising in both bone and soft tissue. Lab Invest. and Mod Pathol. 1997;10:8A.

  132. Bridge JA, Neff JR. Cytogenetic analysis of 76 osteosarcoma specimens over a 10-year period. Lab Invest. and Mod Pathol. 1997.

  133. Rao VH, Singh RK, Bridge JA, Neff JR, Schaefer GB, Delimont DC, Dunn CM, Sanger WG, Buehler BA. Regulation of MMP-9 (92 kDa Type IV Collagenase/Gelatinase B) expression in stromal cells of human giant cell tumor of bone. 88th Annual Meeting of American Association for Cancer Research, San Diego, CA, April 12-16, 1997.

  134. Rao VH, Singh RK, Schaefer GB, Delimont D, Bridge JA, Neff JR, Garvin BP, Sanger WG, Buehler BA. Induction of MMP-9 expression in stromal cells of giant cell tumor of bone (GCT) by TNG-alpha. 50th Annual Symposium on Fundamental Cancer Research, Houston, TX, October 1997.

  135. Wiebolt VM, Forus A, Simons A, Bridge JA, Geurts van Kessel A, Süjikerbuijk RF. Application of comparative genomic hybridization in the analysis of genomic changes in malignant fibrous histiocytomas [platform presentation]. Connective Tissue Oncology Society Annual Meeting, Milan, Italy, November 8, 1997.

  136. Conroy BP, Iversen PL, Norris JS, Bridge JA, Neff JR. Antisense oligonucleotides as potential therapeutic agents in the treatment of osteosarcoma. Orthop Transactions. 1996.

  137. Rao VH, Schaefer GB, Bridge JA, Neff JR, Sanger WG, Singh RK, Delimont D, Buehler B. Stromal cells of human giant cell tumor of bone (GCT) produce 92 kDa Type IV collagenase/gelatinase B (MMP-9). Nebraska Symposium on Cancer and Smoking Related Disease, 1996.

  138. Brody RI, Ueda T, Jhanwar SC, Bridge JA, Healey JH, Huvos AG, Gerald WL, Ladanyi M. Molecular diagnosis of extraskeletal myxoid chondrosarcoma. Am J Pathol. 1996;149:1785.

  139. DeBoer J, Gutkin D, Seemayer T, Schaefer GB, Bridge JA. In-situ hybridization of gonadal tissue from sex chromosome aneuploid individuals. Clin Res.

  140. Bridge JA, Seemayer T, Gutkin D, DeBoer J. In situ hybridization of gonadal tissue from sex chromosome aneuploid individuals. Ped Pathol Lab Med. 1995;15:354.

  141. Bridge JA, Sanger WG, Seemayer T, Gutkin D, DeBoer J. Gonadal sex chromosome complement in individuals with sex chromosomal and/or gonadal disorders. Am J Hum Genet.

  142. Gutkin, DW, Bridge JA, Seemayer TA. Use of Fluorescence in situ hybridization to determine XO/XY mosaicism in a phenotypic male with stigmata of Ullrich-Turner Syndrome. Mod Pathol. 1995;8:143A.

  143. Bridge JA, Taylor R, Raval P, DeBoer J, Bohl K, Johansson S. Interphase cytogenetics: a new approach in the diagnosis and follow-up of bladder cancer. American Society of Cytopathology 43rd Annual Scientific Meeting, New York, NY, November 12, 1995.

  144. Bridge JA, Bhatia PS, DeBoer J, Neff JR. Etiologic, diagnostic and prognostic significance of clonal cytogenetic aberrations in cartilaginous neoplasms. J Bone Joint Surg I.

  145. Bridge JA, Gutkin DW, Seemayer TA. U.S. of Fluorescent in situ hybridization in formalin-fixed paraffin-embedded tissue. American Society for Clinical Pathology/College of American Pathology Fall Meeting, 1994.

  146. Bridge JA, DeBoer J, Travis J, Johansson SL, Elmberger G, Noel SM, Neff JR. Simultaneous interphase cytogenetic analysis and fluorescence immunophenotyping of dedifferentiated chondrosarcoma. Implications of histopathogenesis. Clinical Digest Series.

  147. Rao VH, Bridge JA, Neff JR, Schaefer GB, Vishwanatha JK, Sawaya R, Rao JS. Expression of 72-kDa and 92-kDa Type IV collagenases in human giant cell tumors of bone. The XVI International Congress of Biochemistry and Molecular Biology, India, September 1994.

  148. Bridge JA, Bhatia PS, Anderson J, Neff JR. Biological and clinical significance of cytogenetic and molecular cytogenetic analyses of 120 cartilaginous neoplasms. American Society of Clinical Oncology Program/Proceedings. 1993;12:469.

  149. Pickering D, Bridge JA. Cytogenetic findings in chordoma. Applied Cytogenetics. 1993;19:129.

  150. Travis J, Bridge JA. Trisomy 12 in osteofibrous dysplasia of the tibia. Applied Cytogenetics. 1993;19:134.

  151. DeBoer J, Neff JR, Bridge JA. Cytogenetic and molecular cytogenetic findings in dedifferentiated chondrosarcoma. Cancer Genet Cytogenet. 1993;66:150.

  152. Bridge JA, Bhatia PS, Anderson J, Neff JR. Biological and clinical significance of cytogenetic and molecular cytogenetic analysis of 120 cartilaginous neoplasms. Proceedings of the 7th International Symposium on Limb Salvage, ISOLS. Current Trends. 1993;67-70.

  153. Bridge JA, Neff JR. The diagnostic and prognostic significance of cytogenetic analysis in giant cell tumors. Transactions of the 38th Annual Orthopaedic Research Society Meeting. 1992;17:195.

  154. Howard ST, McComb RD, Olney A., Trembath J, Bridge JA. Lissencephaly in 18p-syndrome: chromosomal and phenotypic variability. 24th Annual March of Dimes Clinical Genetics Conference: Clinical and Molecular Cytogenetics of Developmental Disorders. Am J Med Genet. 1992;60:183.

  155. Travis JA, Bridge JA, Sandberg AA. Standard cytogenetic and combined fluorescent interphase cytogenetic and desmin analysis of malignant triton tumor. AAAS. Science Innovation. 1992;1:58.

  156. Bridge JA, Neff JR, DeBoer JM, Sinovic J. Cytogenetic findings in 100 cartilaginous neoplasms: biological and clinical significance. Cancer Genet Cytogenet. 1992;63:126.

  157. Bridge JA, Sreekantiah C, Mouron BS, Neff JR, Sandberg AA. Cytogenetic findings in desmoid tumors. Cancer Genet Cytogenet. 1991;56:122.

  158. Persons DL, Bridge JA, Berger C, Neff JR, Sandberg A. Cytogenetic findings in enchondromas. Cancer Genet Cytogenet. 1991;56:119.

  159. Mouron BS, Bridge JA, Pfiefer M, Neff JR. Chromosomal normality in aneurysmal bone cyst. Cancer Genet. Cytogenet. 1991;56:119.

  160. Bridge JA, Neff JR. Cytogenetics of 226 bone lesions: pathogenic, diagnostic, and clinical relevance. Am J Hum Genet. 1991;49:239.

  161. Mouron BJ, Bridge JA. Telomeric fusion in benign and malignant bone and soft tissue tumors. Applied Cytogenetics. 1990;16:58.

  162. Bridge JA, Neff JR, Sanger WG. Cytogenetic analysis of benign and malignant bone and soft tissue neoplasms. Cancer Res Clin Oncol. 1990;116:168.

  163. Neff JR, Gemer L, Smalley S, Bridge JA. Intraoperative radiation therapy in the management of patients with nonmetastatic high-grade soft tissue sarcomas. Cancer Res Clin Oncol. 1990;116:517.

  164. Bridge JA, Sanger WG, Neff JR. Cytogenetic analysis of benign bone tumors. Cancer Genet Cytogenet. 1989;41:272.

  165. Bridge JA, Bhatia PS, Neff JR. Diagnostic and prognostic importance of cytogenetic abnormalities in GCTs. American Society of Clinical Oncology Proceedings. 1989;8:421.

  166. Bridge JA, Sanger W, Neff J. Cytogenetic findings in soft tissue sarcomas. Cancer Genet Cytogenet. 1987:28-40.

  167. Sanger WG, Armitage JO, Bridge JA, Weisenburger D, Linder J, Purtilo D. Serial cytogenetic studies in malignant lymphoma. Proceedings of the American Academy of Clinical Research. 1985;26:183.

 

Previous
Next